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Thesis Abstract 
 
Pulses (legumes) are a common dietary constituent of ethnic communities 
exhibiting lower rates of cardiovascular disease (CVD). The following 
studies examined the effect of including chickpeas in an ‘Australian’ diet 
on CVD risk factors. Participants were free-living volunteers aged 30 to 70 
years.  
 
Study 1 investigated the effect of chickpeas on serum lipids, lipoproteins, 
glycaemic control, bowel function and satiation (degree of fullness leading 
to meal cessation) compared to a higher-fibre wheat-supplemented diet 
(Chapter 2). Participants completed two controlled dietary interventions 
(chickpea-supplemented and higher-fibre wheat-supplemented), isocaloric 
with their usual dietary intake, in random order. The design of the 
intervention diets was for matched macronutrient content and dietary fibre 
however increased consumption of polyunsaturated fatty acids (PUFA) 
during the chickpea-supplemented diet was noted. Small but significant 
reductions in mean serum total cholesterol and low density lipoprotein-
cholesterol (LDL-C) were reported following the chickpea diet compared to 
the wheat. Statistical analysis suggested a relationship between increased 
consumption of PUFA and reduction in cholesterol during the chickpea 
intervention but could not discern the source of PUFA. Chickpea 
supplementation did not adversely affect bowel function and participants 
found them very satiating. There was no effect on glycaemic control. A 
small, sub-study compared the effects of an isocaloric, lower-fibre wheat 
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diet to the higher-fibre wheat, to evaluate the effect of quantity of fibre as 
well as source on bowel health and satiety. During the lower-fibre wheat 
intervention, some participants reported lower satiation, and poorer bowel 
health. 
 
Some of the results from this study were included in a larger, collaborative 
study investigating the effect of chickpeas on serum lipids and lipoproteins 
in two centres, Launceston and Melbourne. The Melbourne group followed 
a similar controlled, random crossover comparison of a chickpea-
supplemented diet to a higher-fibre wheat-supplemented diet, also 
endeavouring to match macronutrient content and dietary fibre. The 
Melbourne group also reported small but significant reductions in mean 
serum LDL- and total cholesterol but reported discrepancies in 
consumption of PUFA as well as dietary fibre between the intervention 
diets. Statistical analysis of the combined results suggested a relationship 
between increased consumption of PUFA and dietary fibre and a reduction 
in cholesterol during the chickpea intervention. Appendix 1 is a description 
of this collaborative study, formatted as a scientific paper, accepted for 
publication.  
 
Study 2 investigated whether results from the controlled study would 
translate to ad libitum situations (Chapter 3). The study followed an 
ordered crossover design where participants followed their habitual ad 
libitum dietary intake for four weeks (familiarisation phase), incorporated a 
minimum of four 300g (net weight) cans of chickpeas per week for 12 
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weeks and then resumed their habitual diet for another four weeks (usual 
phase). Small but significant reductions in body weight, body mass index 
(BMI), serum TC, fasting insulin and HOMA-IR occurred following the 
chickpea phase, compared to the post-chickpea usual phase. Results 
suggested that participants positively altered their eating pattern during the 
pre-chickpea familiarisation phase, sustained these changes during the 
12-week chickpea phase but regressed during the usual phase. 
Participants consumed significantly more dietary fibre and PUFA during 
the chickpea phase and less total fat and saturated fatty acids (SFA) 
compared to the usual phase. Perceived bowel health remained constant 
throughout the study, while satiation increased significantly during the 
chickpea phase along with a small but significant reduction in mean body 
weight. 
 
 Incorporating chickpeas into an ‘Australian’ style diet resulted in increased 
consumption of PUFA and dietary fibre that produced small but significant 
reductions in serum TC, BMI and glycaemic control, high satiation and little 
effect on bowel function. Individuals wishing to reduce CVD risk may 
choose to include chickpeas in their diet. 
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Chapter 1  
 
General Introduction 
Worldwide, the rate of increase in chronic, non-communicable diseases such 
as cardiovascular disease (CVD), diabetes, obesity, hypertension and some 
cancers is fast outstripping that of communicable infectious diseases. In 
2001, 60% of global mortality and 46% morbidity were due to non-
communicable diseases (182), CVD in particular. While age standardised 
death rates in many of the wealthier countries have fallen from their peak of 
the 1950’s and 1960’s, rates in many developing countries are now on the 
rise – especially in Central Europe (2, 104), India (131) and China (182). The 
hypotheses advanced for the increases in CVD in these countries cite 
changing dietary, exercise and lifestyle patterns partly related to changing 
socioeconomic circumstances of the populations (2, 104). In some countries 
during the last decade, prevalence of obesity has tripled (182). The forecast 
is that by 2020, 75% of global deaths will be due to non-communicable 
diseases and 75% of those will occur in developing countries (182). 
 
The INTERHEART Study (189) examined if modifiable factors associated 
with development of CVD in America and Western European countries, were 
present to the same degree (population attributable risk – PAR) in other 
countries and ethnic populations. It was found that the following nine factors 
accounted for 90% of PAR in men and 94% in women, regardless of age or 
ethnicity: abnormal lipid profile, tobacco smoking, psychosocial factors 
(financial-, social-, or employment–related stress), abdominal obesity, 
 2
hypertension, lack of daily consumption of fruit and vegetables, lack of 
regular physical activity, diabetes and alcohol consumption more than three 
days per week. Seven of the nine factors have a diet-related association. 
 
1.1 The diet-heart hypothesis 
The diet-heart hypothesis suggests that differences in dietary habit, rather 
than racial or genetic differences, are responsible for the variation in CVD 
mortality rates between ethnic populations (12, 23, 66, 77). A number of 
epidemiological studies conducted in the 1950’s and 60’s such as the Ni-
Hon-San study (140 356), the Ireland-Boston Diet-Heart Study (89 43) and 
the Seven Countries Study (111, 176) demonstrated this. In the early 1970's, 
Burkitt and Trowell examined the link between the rate of ‘non-infective’ 
diseases - such as coronary heart disease (CHD), bowel disease, obesity 
and diabetes, and changes to the traditional diets of urban-dwelling Africans 
who had adopted a more ‘Western’ diet and lifestyle (23, 169). It was found 
that the effect of dietary fibre on the gastro-intestinal tract was related to 
caloric intake, bowel health and serum total cholesterol concentrations. 
 
A consequence of these early food pattern studies has been the interest 
shown in traditional world diets; in particular, the Mediterranean Diet and the 
traditional Japanese diet (88, 152). Both diets contain large amounts of 
unprocessed plant-based foods and very little saturated fat or animal-based 
products. Pulses are the common factor in these and other traditional diets, 
consumed in conjunction with cereals or tubers to provide essential nutrients, 
unsaturated fat, protein and dietary fibre (134). Dietary intervention studies 
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such as the Indian Diet Heart Study (156) and the Lyon Diet Heart Study (33) 
have also supported the health promoting nature of intervention diets based 
on beneficial traditional dietary patterns. These patterns include increased 
consumption of dietary fibre, resistant starch, plant protein and unsaturated 
fats (MUFA and PUFA) along with reduced consumption of animal protein 
and saturated fats. In 1990, the World Health Organisation Expert Committee 
on Diet, Nutrition and Prevention of Chronic Diseases, taking heed of 
outcomes regarding comparison of world food patterns, recommended for the 
first time a goal of consuming 400 g/day of fresh fruit and vegetables and 30 
g/day of pulses (70, 120, 150, 156). 
 
1.1.1 Dietary Fat, Carbohydrate and CVD Risk Factors 
Various studies have reported that compared to dietary carbohydrate, dietary 
saturated and unsaturated fatty acids increase high-density lipoprotein 
cholesterol (HDL-C) (65, 86, 112). In addition, most dietary saturated fatty 
acids (SFA) and trans unsaturated fatty acids increase serum total 
cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) 
concentrations, cis unsaturated fatty acids reduced serum TC and LDL-C and 
stearic acid has little or no effect (65, 86, 112, 183). Furthermore, research 
suggests substitution of unsaturated fatty acids for SFA may also improve 
insulin sensitivity (66, 67, 148, 183). Early controlled feeding studies led to 
predictive equations such as that of Keys et al (78) and Hegsted et al (57), 
from which the P:S ratio emerged as a key dietary influence on serum TC 
concentration (52, 86). The P:S ratio (and subsequent P:M:S ratio) provides 
some acknowledgment of in vivo interaction between the three classes of 
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fatty acids which has confounded many studies i.e. whether the observed 
effect is due to an increase in dietary (cis) polyunsaturated fatty acids (PUFA) 
and/or monounsaturated fatty acids (MUFA) or the replacement of SFA (or 
trans unsaturated fatty acids) (86, 183). The importance of consideration of 
the actual type of PUFA (ω-3, ω-6) or MUFA or some case of individual fatty 
acids has since developed further (65, 86, 112, 183). 
 
Substitution of SFA by complex carbohydrate also reduces serum TC and 
LDL-C (66, 67). Additional benefits include reduced energy intake (14, 158), 
high satiation (degree of fullness leading to meal cessation) (24, 103) and 
improved bowel function due to the effect of viscous soluble and insoluble 
dietary fibre (19, 28, 53, 158, 167) and improved glycaemic response, 
particularly associated with the resistant starch content (53, 69, 71, 158, 
167). 
 
Obesity is a risk factor for CVD and also for diabetes, sleep apnoea, some 
cancers, gastrointestinal disorders and osteoarthritis and relates to all cause 
mortality (20, 55, 84, 178, 180). Studies have shown that even modest weight 
reduction (≤ 10%) can significantly improve glycaemic response, insulin 
sensitivity and lipid profile (59, 82, 174, 180). Research into optimal diets to 
help combat obesity has suggested reducing dietary total fat, in an effort to 
reduce energy intake and promote weight loss and increasing protein, 
complex carbohydrate and dietary fibre intake to facilitate high satiation (14, 
21, 67, 142, 181). Recent research into biomarkers for satiation and satiety 
(interval between cessation of one meal and initiation of the next) has 
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highlighted the hormones ghrelin and leptin as possible quantitative 
indicators of the effect of dietary manipulation on appetite and energy intake 
(31, 137, 158). 
 
Leptin is a protein secreted predominantly by adipocytes and is regulated by 
insulin-mediated changes in adipocyte triacylglycerols content (56). It acts 
primarily via the hypothalamus to inhibit stimulation of appetite (31, 137, 187) 
but also influences thermogenesis (137), the immune system, 
neuroendocrine function (187), hepatic insulin action, peripheral glucose 
utilization (56) and ghrelin secretion (76). In states of energy balance, content 
and timing of meals does not acutely affect leptin concentrations (31) but in a 
state of fasting, levels drop dramatically, independent of changes to body fat 
mass (54, 56). Re-feeding or insulin administration quickly restores pre-
fasting concentrations (187). Increased concentrations do not elicit the same 
degree of response as reduced levels, suggesting the physiological role of 
leptin is to ensure adequate energy intake in times of scarcity rather than as 
prevention of over-feeding in times of plenty (56, 187). Leptin is more 
sensitive to dietary carbohydrate than fat, so long term, a reduced energy 
high-carbohydrate diet may be more effective at maintaining leptin levels and 
suppressing appetite compared to a reduced energy low-carbohydrate diet 
(31). 
 
Ghrelin is a polypeptide hormone expressed by endothelial cells primarily in 
the fundus of the stomach (137). It also acts in the hypothalamus, by 
stimulating appetite (31, 83, 187). In short-term energy regulation, ghrelin 
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concentration is strongly associated with appetite and hunger ratings (31). 
Food entering the stomach suppresses ghrelin in proportion to caloric load 
(83) but stomach distension does not affect ghrelin concentrations (31, 187). 
Reduced post-prandial ghrelin concentrations slowly return to pre-meal 
levels, contributing to initiation of the next meal (31, 83). In long-term energy 
balance, ghrelin stimulates appetite after weight loss (31). Dietary 
carbohydrate suppresses ghrelin secretion more effectively and for longer 
than dietary fat (31), suggesting diets high in dietary fibre and complex 
carbohydrate should promote higher satiation (via stomach distension) and 
prolong satiety (via ghrelin suppression) compared to high fat meals, leading 
to potential weight loss without hunger. 
 
1.2 Legumes and pulses 
Legumes are one of the oldest cultivated plant foods (48, 115). There is 
evidence of their tillage in South East Asia almost 1000 years before the birth 
of Christ. They grow throughout the Middle East, Africa, the American 
continent, China and India. There are over 13,000 species of legume; of 
which approximately 20 are commonly consumed by humans (43, 48, 134, 
160). The family is divided into two classes: oil seeds (soybean, peanut, lupin 
and winged bean) and grain legumes (dry beans, peas and chickpeas) (48, 
160). The oil seeds are cultivated primarily for their protein and oil content, 
the grain legumes as a protein source (48). Legumes grown for human 
consumption are also known as ‘pulses’, from the Latin word ‘puls’, a form of 
porridge made from dry beans (48, 160). 
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As is illustrated in Table 2.1, legumes abound in plant protein which is rich in 
lysine and arginine, but poor in the sulphur containing amino acids (SAA) 
such as methionine and tryptophan (48, 115, 191). Conversely, cereal grains 
lack lysine but are rich in SAA. Vegetarian-based cultures traditionally 
incorporate legumes into their cereal-based diet, thus accessing the full 
complement of amino acids (43, 48, 134, 184). Legumes are also a good 
source of complex carbohydrate, dietary fibre (viscous soluble and insoluble), 
resistant starch (53, 167), unsaturated fatty acids, vitamins, minerals and 
antioxidants (115, 134, 150, 167). In a report for the United States 
Department of Agriculture (USDA), legumes, as a food group, were found to 
contain the greatest amount of total dietary fibre (mostly insoluble) and the 
least amount of simple sugars (94). 
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Table 1.1 Selected nutrient content per 100g dry raw weight of soybeans and 
chickpeas (legumes) compared to brown rice and wheat (cereals). 
  Soybeans Chickpeas Brown rice Soft wheat
Water g 8.54 11.5 12.4 10.4 
Energy MJ 1.74 1.52 1.52 1.42 
Protein g 36.5 19.3 7.5 10.7 
Total fat g 19.9 6.04 2.68 1.99 
- saturated g 2.88 0.63 0.54 0.37 
- polyunsaturated g 11.3 2.69 0.96 0.84 
- monounsaturated g 4.40 1.36 0.97 0.23 
Carbohydrate g 30.2 60.7 76.2 75.4 
Dietary fibre  g 9.30 17.4 3.40 12.7 
Minerals      
Calcium mg 277 105 33 34 
Iron mg 15.7 6.24 1.80 5.37 
Magnesium mg 280 115 143 90.0 
Phosphorus mg 704 366 264 402 
Potassium mg 1797 875 268 435 
Copper mg 1.66 0.85 0.28 0.43 
Vitamins      
Ascorbic acid mg 6.00 4.00 0.00 0.00 
Riboflavin mg 0.87 0.21 0.04 0.11 
Pantothenic acid mg 0.79 1.59 1.49 0.85 
Folate mcg 375 557 20.0 41.0 
Modified from (172) 
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1.2.1 Pulses and lipid profile 
One of the earliest dietary intervention studies involving pulses was that of 
Meeker and Kesten in 1940 (87). They demonstrated that in rabbits, animal 
protein (casein) was potentially more atherogenic than plant protein (soy). A 
difference in amino acid composition of the two proteins was hypothesised as 
the responsible feature. Subsequent studies in animals supported the results 
of Meeker and Kesten, but results of studies in humans have been less 
convincing (8). In 1995, the effects of dietary soy protein on serum lipid 
concentrations in humans were investigated via meta-analysis (8). Twenty-
nine articles published during the years 1967 to 1994, reporting on 38 studies 
were evaluated. Analysis indicated that 31 g - 47 g of soy protein per day 
might significantly reduce the levels of TC, LDL-C and triacylglycerols in 
hypercholesterolaemic individuals. Sixty to seventy percent of the effect of 
soy protein was attributed to the effect of soy oestrogens (8). The 
hypocholesterolaemic effect of soy oestrogens has been supported by a 
more recent meta-analysis of 23 randomised controlled studies conducted 
between 1995 and 2002 (190). Included were studies investigating the effect 
on serum lipid profile of soy protein with isoflavones intact, soy protein 
depleted of isoflavones and purified isoflavones. Only soy protein with 
isoflavones intact was associated with significant reductions in serum TC, 
LDL-C and triacylglycerols and small but significant increase in serum high-
density lipoprotein cholesterol (HDL-C). This was postulated as being due to 
an interaction between the soy protein and associated isoflavones. 
Degradation of protein and/or isoflavones during the extraction procedure 
used to isolate them might have been a reason no hypolipidaemic effect was 
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observed with either depleted soy protein or purified isoflavone extract. As 
with the previous meta-analysis, the effect of soy was greater in 
hypercholesterolaemic subjects but also greater in men compared to women 
and in pre-menopausal compared to post-menopausal women. The latter 
finding supports the suggested mechanism of action of soy (plus isoflavones) 
on lipid metabolism through the biological similarity of isoflavones to 
oestrogen. It was suggested the effect of soy isoflavones on the lipid profile 
was inconsistent, due to the heterogeneity of results. This last point is 
supported by a science advisory from the American Heart Association (42), 
stating soy protein plays only a minor role in lowering LDL-C and its benefit is 
probably indirect – substitution of animal protein leading to reduced 
consumption of SFA and dietary cholesterol. 
 
Proposed mechanisms of action of pulses on blood lipid profiles include 
enhancement of bile acid excretion - resulting in reduced absorption and 
increased excretion of cholesterol and increased bile synthesis; disruption of 
the hepatic metabolism of cholesterol and hormonal effects. Enhancement of 
bile acid excretion has only been successfully demonstrated in some animal 
models (7, 8, 40, 132). Direct effect on hepatic metabolism of cholesterol has 
been suggested to occur in one of three ways: increase in HMG-CoA 
reductase activity; increased removal of LDL-C and very low density 
lipoprotein cholesterol (VLDL-C) by hepatocytes and human mononuclear 
cells and/or increase in cholesterol saturation of bile (7, 40, 119, 132, 190). 
Hormonal effects include possible increases in thyroid hormones, resulting in 
changes to hepatic metabolism of cholesterol and a decrease of the 
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insulin:glucagon ratio – an indicator of insulin resistance (8, 132). While many 
of these mechanisms are attributed to soy protein in particular, other 
compounds that may have an effect include saponins, phytic acid, trypsin 
inhibitors, dietary fibre, isoflavones, sterols and stanols (132, 190). 
 
Leguminous protein is rich in arginine (and its precursor L-glutamine), the 
amino acid substrate for endothelial nitric oxide – an important modulator of 
vascular tone, haemodynamics and endothelial function. Arginine itself also 
has physiological effects independent of nitric oxide, including modulation of 
immune function and inflammatory response, insulin and glucagon secretion 
and regulation of cardiovascular function (34, 168, 186). 
 
All legumes contain less desirable constituents termed antinutrients or 
antinutritional factors (36, 48). Until recently a number of this group of 
compounds were considered detrimental to good nutrition and hence the 
name. Some, such as lectins (haemagglutinins) and the lathyrus toxin, are 
toxic to humans, and others such as the oligosaccharides raffinose and 
stacchyose are responsible for the flatulence often associated with 
consuming pulses (48, 114). Even so, it is the other fermentation products of 
oligosaccharides - short chain fatty acids such as propionates and acetates, 
which are thought to play a role in the interruption of hepatic cholesterol 
synthesis (7, 51). 
 
Protease inhibitors to enzymes such as trypsin and chymotrypsin inhibit the 
digestion of proteins and α-amylase inhibitors such as tannins and phytic 
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acid affect the digestion of carbohydrates (48). While pulses are a rich source 
of vitamins and minerals, the effects of phytates and oxalates reduce the 
bioavailability of these essential compounds (48, 115, 126). However, recent 
studies suggest that phytic acid and the ‘trypsin and chymotrypsin inhibitor’ 
may have antioxidant effects (114) and the effect of phytic acid on nutrient 
absorption has only been shown in vitro (43). In addition, the low 
concentration of inhibitors ingested at usual levels of fibre consumption may 
result in minimal interference of nutrient absorption (43). 
 
Saponins are a common constituent of pulses. They are poorly absorbed and 
contribute to the poor absorption of other nutrients (51). They achieve this by 
forming insoluble complexes with the mixed micelles containing bile salts and 
cholesterol. Animal studies have suggested that these micelles may 
contribute to reduced absorption of bile and cholesterol from the intestine and 
thus contribute to enhanced bile acid excretion (114). Plant sterols and 
stanols may also contribute to reduced cholesterol absorption from the 
intestine by replacing it in the mixed micelles and being transferred into the 
enterocytes instead of cholesterol (32). 
 
Many studies have suggested that soluble fibre has a greater effect on 
lowering human serum lipid levels than insoluble fibre. One literature review 
investigating the hypocholesterolaemic effect of dietary fibre from a number 
of food sources (50) suggested that soluble fibre lowered serum TC and LDL-
C but had no effect on serum HDL-C or triacylglycerols. The food sources 
investigated included pulses (dried beans, peas, chickpeas, lentils); cereal 
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grains and brans; fruit pectin, guar gum (from a leguminous seed), psyllium 
and other sources of dietary fibre. Discussing factors to consider when 
evaluating fibre studies, the authors noted the influence of the type and 
amount of fibre in the test and control diets, the effect of the fibre 
supplements on the fat and carbohydrate content of the diets and the 
baseline lipid levels of the participants. 
 
A dietary intervention trial (153) researching the effect of soybean 
polysaccharide reported a significant reduction in plasma TC  in 31 free-living 
volunteers aged between 25 and 67 years with mildly elevated TC. The 
participants consumed cookies and croutons containing either 25g of soy 
polysaccharide per day or starch placebo during two consecutive, 
randomised crossover dietary periods.  There was an order effect however, 
with the polysaccharide/placebo group showing an 11% decrease in plasma 
TC (28mg/dl) compared to a 5% decrease for the placebo/polysaccharide 
group (11 mg/dl). An ordered crossover study (95) reported that adding 25 
g/day of soy fibre to an already low-fat low-cholesterol diet resulted in a 
further reduction in serum TC of 13 mg/dl and in LDL-C of 12 mg/dl (p<0.05) 
after that elicited by the 12-week low-fat low-cholesterol diet alone. These 
results suggest a hypocholesterolaemic effect of dietary fibre independent of 
baseline lipid level but the study only comprised 11 individuals.  
 
Another intervention study observed the effect of pulses on serum lipids and 
lipoproteins when added to an already low-fat diet (75). In this case, 
significant decreases in serum TC (7%) and triacylglycerols (25%) were 
 14
reported after 16 weeks consumption of a low fat diet in which 25% of total 
energy per day from carbohydrate was supplied by pulses.  Serum LDL and 
HDL-C concentrations were unaffected. While the fat, protein and 
carbohydrate content of the altered diet was held constant, dietary fibre and 
starch content were increased by 66% and 12% respectively. There was also 
a significant reduction in dietary cholesterol (32%), perhaps due to the higher 
leguminous protein content replacing some animal protein in the diet. Even 
so the result must be treated with caution because the study population was 
very small and of only one gender – male. After the trial, five of the seven 
men chose to continue including legumes in their diet; a move interpreted by 
the authors to indicate easy acceptability of legumes into a Western diet; 
however, no follow-up was reported, so there was no indication of the 
permanence of the dietary change. 
 
A controlled, parallel, dietary intervention study compared the effect of two 
test diets - oat bran and dry bean products (pinto and navy beans) to a 
control diet on the blood lipids of 20 hypercholesterolaemic men (34 to 66 
years old) while they were in-patients on a metabolic ward (10). The test 
diets were of 21 days duration, following on from a seven-day control diet. 
Both test diets were isocaloric with their respective control diets except for 
dietary fibre (approx. 60% more total and 65% more soluble fibre). Results 
demonstrated a 19% reduction in serum TC following both test diets and a 
23% reduction in LDL-C following the oat-bran diet and a 24% reduction 
following the bean diet compared to their control diets. Although serum HDL-
C levels were reduced after both test diets (oat bran: 6% less; bean: 13% 
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less), the HDL:LDL ratio increased by 17% and 22% respectively. There was 
an average weight reduction of 1.0 kg - 1.3 kg during both the test diets, 
which was statistically significant compared to their respective control diets 
but not between the two test diets. Energy consumption during the bean diet 
was slightly lower than the control but not significantly different. The bean 
group consumed slightly more PUFA and slightly less SFA during the test 
phase but the difference was not statistically significant from their control diet 
or the oat-bran group. These small differences in energy and nutrient intake 
may have affected serum cholesterol concentrations during the bean diet to a 
minor degree but no such differences in nutrient intake were apparent during 
the oat-bran diet and there was no significant correlation between change in 
serum TC and weight reduction. After the trial, participants were encouraged 
to continue on similar diets high in fibre from oat and bean products. Follow 
up of 10 participants after 24 weeks demonstrated continuing reductions in 
TC and LDL-C. Follow up of four participants after 99 weeks demonstrated 
an increase in HDL-C. These continued changes may have been due to 
adherence to a high fibre diet but other lifestyle changes that often 
accompany dietary change (eg. increased physical activity and weight loss) 
may have also contributed to the continuing changes in lipid profile. Results 
from such a small group would be difficult to interpret. 
 
Some animal studies examining the effects of legumes have also reported 
reductions in LDL-C concentrations. One intervention study recorded the 
effects of hypocholesterolaemic diets supplemented with four different 
legumes (baked beans, peas, lentils, butter beans) on the lipid profile of pigs 
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(81). After six weeks, results indicated all four diets significantly inhibited 
hypercholesterolaemia by suppression of LDL-C and VLDL-C production. 
Another study compared the effects of diets supplemented with either cereal 
or legume fibre, on the lipid profiles of hypercholesterolaemic rats (166). The 
legume diets produced significantly lower plasma and tissue LDL-C and 
VLDL-C levels compared to the cereal diets. The physical and chemical 
properties of cereal and legume fibres were also analysed. Results indicated 
soy and chickpea fibre to have greater bile binding capacity than fibre from 
wheat or maize. Consequently, it was suggested that the 
hypocholesterolaemic effect of legume fibre was associated with its greater 
bile binding capacity. It was argued that this property was responsible for 
reduced reabsorption of bile in the colon, resulting in increased bile synthesis 
and reduced cholesterol synthesis. However, while these studies may 
provide proof of concept and help explain possible mechanisms for the 
hypocholesterolaemic effect of legume fibre, the results cannot be directly 
translated to the human condition. 
 
Comparison of fibre from oat-bran and beans was the subject of an 
intervention study investigating their effects on human serum lipids and 
lipoproteins in combination with a low-fat diet (99). The study population 
numbered 39 free-living, hypercholesterolaemic men and women, aged 28 to 
66 years. The intervention diets were administered in a random crossover 
design. They differed in the source of dietary fibre (beans or oat-bran) and 
the amount of ß-D-glucan content (high fibre oat-bran or low fibre oat-bran). 
In contrast to the study of Anderson et al (1984) (10), results of this study 
 17
indicated a small but significant increase in plasma HDL-C after all three test 
diets but no significant effect on LDL-C or TC. It was suggested that other 
studies might not have detected a rise in HDL-C due to an inadvertent 
reduction in saturated fat intake or changes to the P:S ratio. These changes 
may have been responsible for reducing serum HDL-C levels, thereby 
masking any rise due to other dietary factors (99). 
 
Another intervention study found no change in the serum lipid levels of nine 
healthy human males aged 19 to 28 years, subjected to three weeks of a 
typically Western diet supplemented with green lentils (163). The authors 
proposed that the lack of effect on serum lipids might be due to the normal 
baseline lipid profiles of their participants (7, 22, 50), or the fibre composition 
of lentils, which is primarily insoluble fibre. Then again, the length of the 
intervention diets may not have been long enough to allow a significant 
change in serum lipids to take place (4, 145, 146) and the study may not 
have been powerful enough to detect a difference in serum lipid levels due to 
the small number of subjects. 
 
While animal and human dietary intervention studies have indicated a 
potentially beneficial effect of legumes on serum lipids, observational studies 
are inconclusive regarding an association between legumes and reduction in 
CHD mortality (90). An epidemiological study in support of an inverse 
relationship between legume consumption and CHD, is the follow up of the 
First National Health and Nutrition Examination Survey (NHANES 1), the 
Epidemiologic Follow up Study (NHEFS) (17). The study consisted of results 
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from 9632 men and women, aged between 25 and 74 years at baseline, 
collected over a period of 19 years. Legumes (‘dry beans and peas like pinto 
beans, red beans, black-eye peas, peanuts and peanut butter’) were one of 
13 food categories included in a three-month recall, food frequency 
questionnaire, conducted at baseline. At the completion of the study, the 
investigators reported a strong inverse association between dietary intake of 
legumes and risk of CHD, independent of the other established CHD risk 
factors such as smoking and saturated fat intake. It must be noted, however, 
that information on portion size was not collected in the questionnaire but 
estimated by one 24-hour dietary recall. Depending on the time of year, a 
three-month dietary recall may be subject to seasonal variation in diet. Thus, 
the accuracy of legume intake might be questioned. In addition, legume 
consumption (and overall dietary intake) was estimated at baseline only – 
change in dietary habit was not assessed during the 19-year follow-up. While 
‘in depth interviews’ were performed during follow-up, no details are given as 
to assessment of lifestyle changes that may have confounded the outcomes.  
 
A meta-analysis of clinical trials investigating the effects of ‘non-soya pulses’ 
concluded that regular consumption of pulses may protect against risk of 
CVD (9). Eleven clinical trials conducted over the previous 20 years were 
identified and although they varied greatly in design and setting, the authors 
included all of them ‘to avoid biases’. Meta-analysis revealed a decrease in 
TC of 7% and LDL-C of 6% associated with the ingestion of pulses but no 
effect on HDL-C. No mention is made of the required amount of pulses that 
would bring about this level of decrease in serum lipids. It was postulated that 
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the hypocholesterolaemic effect of pulses was due to a combination of their 
nutrient components (eg soluble fibre, vegetable protein, oligosaccharides, 
isoflavones, phospholipids and fatty acids), rather than the individual 
components themselves. It was suggested that an increased consumption of 
pulses may have a beneficial effect on other CVD risk factors such as 
obesity, diabetes and hypertension in addition to hypercholesterolaemia. 
 
1.2.2 Pulses and glycaemic control 
Following on from studies into the healthful effects of dietary fibre by Burkitt 
and Trowell, researchers became interested in the effect of dietary fibre on 
glycaemic response (100, 155). It had been noted that different sources of 
carbohydrate had differing effects on post-prandial blood glucose levels, 
depending on the physical form of the food, the nature of the carbohydrate, 
the amount of dietary fibre and the presence of other macronutrients (74, 97, 
165). The glycaemic index (GI) was devised to predict the effect of an equal 
quantity of carbohydrate in a food on post-prandial glycaemic response 
compared to a control food – initially a combination of cottage cheese and 
white bread (73). Foods categorised as low GI produced a lower, flatter 
glycaemic response, reflecting the slower, steadier rate of glucose absorption 
over a longer period, from food more slowly digested, allowing the body 
easier transition from the ‘post-prandial to post-absorptive state’ (73, 97). The 
glycaemic load (GL) better reflects the ‘glycaemic impact’ of a food portion 
(15) by taking into account the amount of available carbohydrate as well as 
its GI. Thus, a carrot and a potato both have a high GI but the carrot has a 
low GL because there is less carbohydrate per standard serve (97). Diets 
 20
containing large amounts of high GI and GL foods contribute to higher fasting 
and post-prandial blood glucose and insulin concentrations in both diabetic 
and non-diabetic individuals, possibly resulting in greater risk of developing 
diabetes, heart disease and cancer (165). In addition, the post-prandial 
response to a high GI meal often results in insulin-induced hypoglycaemia 
with ensuing desire for additional food intake, leading to unnecessary weight 
gain (97). 
In a study comparing the effect of fibre from different sources, soy hulls were 
included as one of three processed fibres tested (100). After four weeks of 
daily supplementation of their habitual ad libitum diet with either 26 g or 52 g 
soy hull fibre, incorporated into bread, 18 free-living adults diagnosed with 
non-insulin dependent diabetes mellitus (NIDDM) recorded very slight 
improvements in glycaemic control compared to the white-bread four-week 
control phase. Improvements occurred in fasting plasma glucose, glucose 
score and post-prandial glucose tolerance testing after a formula meal. The 
results suggested a ‘lingering’, longer-term effect of soy hull fibre on 
glycaemic response as well as the post-prandial ‘acute effect’. However, 
results were inconsistent between individuals and the groups and 
confounded by variation in bodyweight. 
 
In one of the earliest studies to report on the post-prandial glycaemic effect of 
legumes as a whole food, eight different varieties of dried legume were 
compared to 27 other high carbohydrate foods, including processed legumes, 
dried and processed cereals, cereal products and starchy vegetables (74). 
As a class, legumes produced approximately half the post-prandial glycaemic 
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response of any of the other food groups. This was attributed to their high 
dietary fibre content in combination with starch in a form more resistant to 
digestion. A study examining the effect of legumes common to Indian diets 
on glycaemic response determined that the GI of the foods tested – kidney 
beans, Mung beans, chickpeas, rice and wheat was directly proportional to 
the amount of viscous dietary fibre they contained (38). The hypothesis was 
that viscous polysaccharide increased the thickness of the ‘unstirred’ layer 
surrounding intestinal villi, thereby reducing the rate of glucose absorption. 
More recent studies indicate that glucose absorption is affected by the rate of 
gastric emptying which is in turn affected by the energy density of the diet 
(188). Viscous polysaccharides cause delayed gastric emptying and slower 
intestinal transit, resulting in a reduced rate of glucose absorption (19). 
 
The effect of legumes as a whole food was also investigated in a randomised 
cross-over study using six-week interventions, involving 27 diabetic 
individuals (18 NIDDM and nine insulin dependent diabetes mellitus - IDDM) 
(155). The effect of a high leguminous diet (HL) was compared to a 
‘traditional diabetic diet’ (low carbohydrate, LC), on post-prandial and longer 
term glycaemic response and the serum lipid profile. The HL diet produced 
significantly lower basal, preprandial and two-hour postprandial glycaemic 
responses compared to the LC diet but insulin response, though lower during 
the HL diet was not significantly different. Mean body weight was 0.9 kg 
lower after the HL diet, even though the diets were devised to maintain 
weight but there was no correlation between degree of weight loss and 
glycaemic response. Mean plasma TC was significantly lower after the HL 
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diet compared to the LC but plasma LDL- and HDL- results varied between 
the NIDDM and IDDM groups. Comparison of the intervention diets shows 
them both contributing 21% of total energy (%E) per day from protein. The 
HL diet contributed 61 %E from carbohydrate and 18 %E from total fat. The 
P:S ratio was 1:1 and the dietary fibre intake was 97 g/day. In contrast, the 
LC diet contributed 40 %E from carbohydrate and 39 %E from total fat. The 
P:S ratio was 1:3 and the dietary fibre intake 15 g/day. The glycaemic effect 
of the HL diet was attributed to the ‘large quantities of leguminous fibre’ but 
no distinction was made between differing forms of carbohydrate. The 
hypocholesterolaemic effect of the HL diet may have been due in part to 
substitution of carbohydrate for dietary fat, substitution of PUFA for SFA or 
the effect of high dietary fibre intake. It would be hard to convince diabetics to 
adhere to the HL diet for any length of time, due to the large amount of 
legumes they would be required to consume. 
 
A later study investigating the effect of a high-carbohydrate, high-fibre diet 
(HCHF), utilizing ‘whole-grain or bran cereals, dried beans, vegetables and 
fruits’ compared to a low-fibre, low-carbohydrate diet (LCLF) on glycaemic 
response and lipid profile, reported different results (11). The randomised 
crossover study involved interventions of four weeks duration separated by a 
six-week washout. The HCHF diet provided 10 %E from total fat (P:S ratio 
2:1), 20 %E from protein, 70 %E from carbohydrate (25% simple, 75% 
complex) and 35 g fibre/1000 Cal – 56g/day to 89 g/day (approx. 1/3 soluble 
fibre). The isoenergetic LCLF diet provided 41 %E from total fat (P:S ratio 
1:2), 20 %E from protein, 39 %E from carbohydrate (50% simple, 50% 
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complex) and 5g fibre/1000 Cal – 9 g/day to 13g/day (approx 1/3 soluble 
fibre). Significantly lower mean basal insulin requirements were produced 
during the HCHF diet compared to the LCLF but there were no significant 
differences in mean fasting or post-prandial plasma glucose concentrations. 
Mean baseline body weight was not significantly different between the diets 
and there was no significant change in body weight during the two 
intervention periods. As a measure of peripheral tissue insulin sensitivity, the 
carbohydrate: insulin ratio (C:I) was also determined in this study. This ratio 
compares the amount of carbohydrate consumed to the amount of insulin 
delivered during a set period and it was found to be significantly greater 
during the HCHF diet, compared to the LCLF. This increase in peripheral 
tissue insulin sensitivity was thought to be responsible for reducing the 
amount of insulin required during HCHF diets resulting in improved long-term 
glycaemic response. Other modes of action that may have contributed to 
lower basal insulin response included increased chewing time for the higher-
fibre low-energy dense foods – making eating a longer, slower process; 
slowed gastric emptying due to increased amounts of soluble dietary fibre; 
slower absorption of glucose from the small intestine due to resistant starch 
content; decreased secretion of GIT hormones; increased production and 
absorption of short chain fatty acids (from colonic fermentation of insoluble 
dietary fibre and resistant starch) and their effects on glycolytic enzymes in 
the liver and skeletal muscle (11, 46). As with a number of previous studies, 
the population sample in this study was quite small – ten participants and 
90% male. 
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The effect of HCHF diets on peripheral tissue insulin sensitivity was 
investigated in a small group of healthy young and old adults but again the 
groups were very small (n=12: six younger, six older) (46). In addition, the six 
younger participants were all male but three of the older participants were 
female. A euglycaemic insulin clamp and (6, 6-2H2) glucose measured 
insulin-mediated glucose disposal and hepatic glucose production before and 
after a three to four-week isoenergetic HCHF dietary intervention. In the 12 
healthy adults tested – especially in the six young men, the HCHF diet 
significantly improved insulin-mediated glucose disposal and thus peripheral 
tissue insulin sensitivity, compared to the habitual ad libitum diet of the 
participants with no change in hepatic glucose production. Fasting plasma 
glucose, insulin and serum TC were all significantly reduced following the 
HCHF intervention – serum TC more so again in the six younger men 
compared to the six older adults but serum triacylglycerol concentrations 
remained unchanged. The hypothesis was that the metabolic effects of 
HCHF diets on glycaemic response could be due to effects of dietary fibre on 
either intestinal absorption of glucose, hepatic glucose output or peripheral 
tissue insulin sensitivity. But in this study there were large differences in total 
fat and fatty acid content as well as vast differences in dietary fibre 
consumption during the HCHF intervention compared to the control (the 
participants’ habitual ad libitum diet). During the HCHF diet, mean fibre 
consumption ranged from 70-100 g/day compared to 10-18 g/day normally; 
total fat consumption was 66% less during the HCHF and the P:S ratio 
altered from 1:2 (habitual diet) to 1.5 :1 (HCHF diet) for the younger group 
and from 1:2 to 1:1 for the older group. 
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In more recent articles reviewing the health-benefits of legumes, they are 
described as rich in ‘slow release carbohydrate’ (167), dietary fibre and 
protein (53, 167). The  
resistance of legume starch to digestion compared to cereal starch is 
explained as being due to the higher percentage content of amylose, the 
greater content of retrograded starch in processed legumes and the 
increased protein content (starch-protein interactions). In addition, the 
presence of amylase inhibitors helps neutralise the digestive enzymes; 
phytates form large insoluble nutrient complexes and dietary fibre physically 
binds the starch, preventing or slowing dispersion and reducing exposure to 
digestive processes. Diets high in legumes and low in SFA have been 
suggested to have greatest long-term benefit to individuals suffering from 
diabetes or hypercholesterolaemia (126, 139) although the mechanism is not 
clearly defined (121, 126). Such individuals are commonly also obese (55) 
and weight reduction is known to improve lipid profile and insulin sensitivity 
(59, 82, 173, 174, 185). Some authors believe short term glycaemic change 
is associated with macronutrient change and energy restriction, while longer 
term change in insulin sensitivity is associated with weight loss and altered 
abdominal adiposity (58, 102). Others believe dietary macronutrient content, 
especially SFA and dietary protein are important determinants of peripheral 
tissue membrane permeability to insulin and glucose (91, 164, 177). One 
author suggested the effect of carbohydrate not digested in the small 
intestine is responsible for beneficial consequences to cholesterol and 
glucose metabolism as well as on colonic health and function (126). 
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1.2.3 Pulses and bowel function 
Poor or slow starch digestibility leads to lower, slower glucose absorption in 
the small intestine with greater amounts of starch reaching the large bowel 
where, along with soluble dietary fibre, it is completely fermented, with partial 
fermentation of insoluble fibre (19, 28, 53, 167). Consumption of a high 
protein diet, may lead to undigested protein reaching the large bowel. 
Fermentation of protein leads to formation of toxic, potentially carcinogenic 
compounds such as phenol, cresol, indoles, ammonia and amines (98). 
Increased amounts of fully and partially fermentable carbohydrate result in 
increased growth of colonic microflora, dilution of toxic metabolites, increased 
faecal bulk, shortened bowel transit time and softer, bulkier stools (19, 28, 
53, 167). The production of short chain fatty acids is a by-product of 
carbohydrate fermentation – in particular acetate, butyrate and propionate. 
Fermentation of soy fibre leads to increased synthesis of propionate and 
butyrate compared to other highly fermentable fibres (53). Absorbed 
propionate is hypothesised to interfere with hepatic cholesterol (19, 28, 53, 
167). and glucose metabolism (126), to enhance colonic muscular 
contractions and increase colonic blood flow (167). Butyrate is the nutrient of 
choice for normal colonocytes, reducing risk of malignant transformation and 
colon cancer.  
 
One study investigating the effect of leguminous dietary fibre on human 
colonic function overall, examined how supplementing a ‘Western’ diet 
(control diet) with 130 g/day of green lentils (lentil kernel fibre - LKF diet) for 
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three weeks affected colonic function (163). Again the population group was 
very small and only one gender– nine healthy adult men. The diets were 
isoenergetic and similar in macronutrient content, apart from dietary fibre 
(non-starch polysaccharide – NSP) consumption, which was 11.8 g/day more 
during the LKF diet due to the lentils. It was found that during the LKF diet 
faecal weight increased by 45% and faecal nitrogen excretion increased by 
30% compared to during the control diet. This suggested that the increase in 
faecal weight was due to increased bacterial mass from fermentation of NSP 
rather than increased water holding capacity exhibited by fermentation-
resistant dietary fibre, such as wheat bran. The increase in faecal nitrogen 
was greater than expected from the 75% of lentil NSP fermented because 
other forms of carbohydrate contained in lentils such as oligosaccharides and 
starch ‘resistant to small intestine digestion’ may have contributed. One 
earlier study using navy and pinto beans, found that leguminous fibre did not 
contribute to increased faecal weight while another study using soy 
polysaccharide did. Even though faecal weight increased substantially during 
the LKF diet, mean bowel transit time (BTT) was not significantly different. 
This might have been because the participants, who were healthy young 
men, already displayed relatively fast BTT’s on their usual diets so faster 
times would have been hard to detect. 
 
A more recent study determined the effect of adding pea-hull fibre to the 
usual diet of elderly institutionalised participants (29). The six-week 
intervention involved the substitution of wheat flour for 4 g/day of finely 
ground pea-hull fibre in the usual meals of 114 elderly men and women. This 
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increased the mean daily dietary fibre intake from 16 g to 20 g – if all 
foodstuffs were eaten. The frequency of administration of laxatives and 
enemas and the number of bowel movements experienced by the 
participants during a four-week baseline period was compared with the 
middle four-weeks of pea-hull treatment. The pea-hull fibre used had a total 
dietary fibre content of 78% - 71% insoluble and 7% soluble fibre. There was 
a significant increase in bowel movements per month for all residents during 
the pea-hull treatment compared to baseline. A small group of residents with 
bowel movements of less than ten per month during baseline, considered at 
risk of constipation, also showed a significant increase in bowel movements 
during the pea-hull treatment. Frequency of administration of fruit/prune 
puree was reduced but not administration of laxatives or enemas during the 
pea-hull treatment but this may have been due to overuse of the procedure 
rather than no change in need of administration. Acceptance of the pea-hull 
fibre and the bowel health benefits were such that the institution continued to 
incorporated pea-hull fibre in the menus offered to their residents after 
completion of the study. 
 
1.3 Chickpeas 
Chickpeas are most commonly associated with the cuisine of the 
Mediterranean and Asia - especially India (48, 160). The number of 
synonyms: Bengal gram, boot, kabli chana, chana chola, chole, kaala, gram, 
hommes, pois chiche, garbanzo bean, barbarzo bean, is consistent with a 
long history of use throughout these regions. The scientific name, Cicer 
arietinum, is derived from the Roman name for chickpeas. The Roman 
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family, Cicero, took their name from the chickpea, and arietinum is the 
Roman word for ram. Apparently, the shape of the chickpea looks like a 
ram's head - complete with curling horns (48, 160).  
 
The two cultivars, Desi and Kabuli, are grouped according to seed colour and 
geographic distribution. Desi are common to India. They are smaller and 
range in colour from fawn to brown, yellow, orange, black or green. They are 
eaten either whole, as dhal (puree) or dhal flour. The Kabuli cultivar is more 
common to the Mediterranean. The pea is larger, white in colour and usually 
eaten whole. Nutritionally, Kabuli chickpeas are very slightly higher in protein 
content and fat, however Desi chickpeas provide more than three times the 
dietary fibre (129). Chickpeas are the second most cultivated pulse 
worldwide and are third largest in terms of amount of pulse produced 
worldwide (129, 157, 191). They are a very important staple food for 
developing countries because they provide a cheaper form of protein than 
expensive animal sources. In addition, they are easy to grow - even in harsh 
arid environments, and are acceptable to the mostly vegetarian and semi-
vegetarian cultures that inhabit the Indian and Mediterranean regions (129). 
 
Per 100 g, dried chickpeas contain 19.3 g of protein, which compares 
favourably with wheat at 10.7 g. Chickpea protein digestibility (75-84%) is the 
highest among the dry edible legumes, perhaps due to chickpeas having the 
lowest concentration of trypsin inhibitors (18, 68, 122). A big advantage of 
plant-sourced protein over animal proteins is the accompanying nutritional 
extras: dietary fibre, complex carbohydrates and no cholesterol. The 
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carbohydrate of both chickpeas and wheat is composed mainly of starch with 
a small residue of sugars and oligosaccharides (43). Although chickpeas 
contain less carbohydrate than wheat, the starch they do contain has a 
higher amylose content (46%), which renders it more resistant to digestion 
(126, 135). The seed coat of chickpeas is removed as part of the food 
preparation process (dehulling). Thus the dietary fibre content, at 17 g/100 g, 
is not as high as other pulses consumed with their seed coat intact (51). 
Even so, compared to cereal grains chickpeas are a very good source of 
dietary fibre, both soluble and insoluble plus resistant starch. In contrast to 
most other pulses and cereals, chickpeas have a relatively high fat content at 
6 g/100 g. This makes them an important energy source for vegans and 
those without regular access to meat and dairy products. The fat is mostly ω-
6 PUFA, with some MUFA and less than 1% SFA (172). 
 
Chickpeas are a rich source of vitamins, minerals and phytoestrogens. They 
contain folate, thiamine, riboflavin, niacin, pantothenic acid, vitamins C, A and 
E (51). Chickpeas have a higher content of calcium and phosphorus than 
other pulses and are a good source of iron and zinc (114, 129). They also 
contain magnesium, copper, manganese and selenium (51). Chickpeas are 
abundant in the isoflavones formononetin and biochanin A, phytoestrogens 
common to many pulses (108, 118, 149, 151, 154). Chickpeas are relatively 
free of antinutrients, such as lectins, but do contain small amounts of 
saponins, oligosaccharides, some tannins and phytate (51, 129, 134). 
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1.3.1 Chickpeas and serum cholesterol 
Relatively little clinical or nutritional notice has been taken of chickpeas by 
the general scientific community - even though they are an important staple 
food source in third world countries (191). Most of the earlier investigations 
were conducted using laboratory animals, and mainly by Indian investigators. 
In the 1960’s, a series of studies using rats and rabbits resulted in evidence 
that suggested inclusion of chickpeas in the diet would have a significant 
effect against high serum and tissue cholesterol concentrations. In one 
experiment, groups of rats were fed hypercholesterolaemia-inducing diets 
(HID's) supplemented with whole chickpeas, chickpea lipid extract or the 
defatted chickpea residue for a period of six weeks (105). Results of samples 
taken at the completion of the diets suggested that all three forms of 
chickpea supplement significantly reduced raised serum cholesterol in rats. 
As part of the same study, another group of rats were fed HID’s for six weeks 
and then HID's plus one of the three forms of chickpea supplement. Again, all 
three forms of chickpea supplementation prevented a rise in cholesterol but 
no data is given of cholesterol levels at the completion of the HID phase, 
before the supplemented phases began. Furthermore, to keep the diets 
isocaloric, the content of the HID's were changed, depending on which 
chickpea supplement was added. The main differences were in the quantity 
of sucrose in the control diet (60%) compared to the supplemented diets (0%, 
5% or 57%) and the presence of casein in the control and lipid extract diet 
(15%) but not in the whole gram or defatted gram diets. These differences 
could possibly have contributed to the results obtained. 
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The author attributed the hypocholesterolaemic action of the chickpea lipid 
extract to its rich content of linoleic and oleic acid and the 
hypocholesterolaemic action of defatted chickpea residue to the constituent 
proteins. In a follow-up study designed to identify the active proteins, rats 
were fed HID's supplemented with chickpea protein portions fractionated by 
solubility in either water, saline or alkaline solutions (105). Only the saline 
soluble portion was reported to significantly lower serum cholesterol. This 
portion contained the highest concentration of arginine, a protein known to 
exhibit hypocholesterolaemic properties (8, 105).  
 
In 1973 a group of investigators repeated the study of Mathur but they could 
not duplicate the results (124). They used rabbits rather than rats as the 
experimental animal, so perhaps a difference in species lipid metabolism 
may have contributed to a difference in results. Again, the base diet (HID) 
included both sucrose (60%) and casein (15%) and the sucrose was reduced 
in the chickpea-supplemented diet (19%). They reported a marked increase 
in serum lipids in both groups of rabbits and the presence of grade II 
atheromatous lesions. They reasoned that ‘the excess of sucrose’ might have 
been responsible for the atheromatous lesions. No mention was made of the 
possible atherogenic effect of casein.  
 
In an experiment of their own, using a different base diet, Nityanand and 
Kapoor found no change to blood lipid levels or atherosclerosis formation in 
rabbits (124). The rabbits were fed a stock diet supplemented with chickpea 
flour and cholesterol, compared to another group fed a stock diet plus 
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cholesterol. The stock diet contained wheat flour (55%) and chickpea flour 
(20%) compared to the chickpea-supplemented diet, which contained 75% 
chickpea flour. Perhaps the presence of chickpea flour, even at only 20%, 
affected the results obtained using the stock diet. In addition, Nityanand and 
Kapoor did not include casein or sucrose in their base diets and they used a 
different form of chickpea to Mathur. These differences may also have 
affected their results.  
 
Following on from work involving animals, Mathur, Khan and Sharma, 
conducted a dietary intervention study in humans (106). The study involved 
30 healthy middle-aged men (15 to 50 years old) divided into two groups. 
One group of 20, followed a diet supplemented with 156 g of butterfat for ten 
weeks (high-fat diet), then a high-fat-plus-chickpea diet for 55 weeks. The 
control group of ten followed a ‘routine hospital diet’ containing 35 g of fat for 
the whole 65 weeks. The results showed a significant decrease in serum 
cholesterol in 16 out of 20 subjects after the high fat plus chickpea diet. No 
mention is made of weight gain or loss, no mention is made of usual energy 
intake or expenditure and no mention is made of results of the control group. 
The control and test groups were composed of different individuals; differed 
in number of participants, and possibly in mean age and weight. No mention 
is made regarding the study setting e.g. free-living, metabolic ward or 
hospital ward, thus there is no indication of the degree of compliance or 
dietary control. The high-fat and high-fat-plus-chickpea diets were isocaloric 
in total energy consumed but differed in composition of carbohydrate and 
protein. While the fat content of the high-fat and control diets was stated, no 
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mention is made of the actual chickpea content of the high-fat-plus-chickpea 
diet or the amount of ‘wheat flour and other cereals’ the chickpeas replaced. 
Four subjects did not show a reduction in serum cholesterol and it is not 
evident whether their results are included in the mean values published, as 
no indication of the number of results used to calculate the means is given.  
 
One of the first studies to consider the hypocholesterolaemic potential of 
different dietary fibre from pulses compared the effects in rats, of fibre 
derived from five pulses commonly consumed in India: Green gram, Black 
gram, Bengal gram (chickpeas), peas and lentils (159). Six groups of rats 
were fed hypercholesterolaemic diets supplemented with crude fibre isolates 
of each of the five pulses or cellulose (control), for four weeks. Results 
indicated a significant lowering of cholesterol by all five pulses compared to 
the control, however there was no significant difference detected in the 
plasma cholesterol-lowering effect between the pulses. As part of the same 
study, the hypocholesterolaemic effect of fibre as part of the whole pulse was 
compared to the corresponding crude fibre extract. The 
hypocholesterolaemic effect per gram of fibre was significantly different 
between the whole pulses but not between the crude fibre extracts, 
suggesting an additional effect of some other constituent in the whole pulses.  
 
More recently, whole-germinated chickpeas were included in a human dietary 
intervention study (49). The study measured the potential 
hypocholesterolaemic effects of two plant alternatives (chickpeas and garlic) 
to synthetic lipid-lowering drugs. Thirty normal, healthy participants (19 – 21 
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years old) were divided into three equal groups matched for age, weight, sex 
and socioeconomic status, resulting in only ten individuals in each group. The 
two test groups were placed on a controlled diet plus a daily supplement of 
either 100 g of whole-germinated chickpeas or 15 g of garlic, for eight weeks. 
The third, control group consumed the same controlled diet as the test 
groups supplemented with guggulipid at a dose equivalent to 25 mg of 
guggulsterone. Guggulipid is an extract of the resin of the guggul tree 
(Commiphora mukul) and has well documented hypolipidaemic properties 
attributable to a steroid-type compound, guggulsterone (171). At the 
completion of the diets, the chickpea-supplemented group recorded a 17% 
reduction in serum TC, the garlic-supplemented group recorded a 13% 
reduction and the guggulipid reference group recorded a 32% reduction. The 
macronutrient content and energy intake of the ‘controlled diet’ was not 
elucidated, nor compared to the usual diet of the volunteers. The setting of 
the study was not mentioned, however, reference to ‘healthy normal 
volunteers’ suggests a free-living environment. The initial serum TC level of 
the participants determined the three groups. There was no reason given for 
this arrangement. The group with the highest level (mean 212 mg/dl ±  sd 
6.23 mg/dl) was assigned to the guggulipid-supplemented diet; the group 
with the next highest concentration (157 mg/dl ± 4.94 mg/dl) was assigned to 
the chickpea-supplemented diet; the group with the lowest mean initial serum 
total cholesterol (148 mg/dl ± 8.81 mg/dl) was assigned the garlic-
supplemented diet. It has been suggested that the higher the initial blood lipid 
levels of participants, the greater the chance of detecting any change due to 
dietary intervention (5, 48, 138, 175). Thus, the difference in mean initial total 
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cholesterols in the study of Ghorai et al (49) may have influenced the degree 
of change obtained at the conclusion of the three treatments. Coupled with 
the small number of participants in a case-control setting and the lack of 
information regarding the intervention diets and the study design, the results 
from such a poor study are difficult to interpret. 
 
The hypocholesterolaemic potential of chickpeas was not widely 
acknowledged by the Western scientific community until the mid 1990’s. The 
reason for this may have been the preoccupation of the Western scientific 
community with three main areas: S-amino acid deficiency of legume 
proteins, the presence of enzyme inhibitors and the presence of lectins (36). 
This attitude is illustrated by a paper published in 1995 which claims the 
study, ‘of a previously uninvestigated legume’, to be the first to demonstrate 
‘that chickpea consumption may have a corrective effect in some alterations 
of the lipid profile’ (192). The authors compared the effect of a casein diet 
and a chickpea diet on hypercholesterolaemic rats. There was a certain 
degree of emphasis placed on the undesirable qualities associated with 
legume consumption throughout the paper, even though the outcome of the 
study was very positive regarding the status of chickpeas as a 
hypocholesterolaemic agent. Significant lowering of TC, LDL-C, VLDL-C and 
triacylglycerols were reported. This finding was repeated four years later in a 
study, also on rats, using heated chickpeas (191).The chickpeas were 
autoclaved before inclusion in the test diet, in the belief that ‘some anti-
nutritive factors may be reduced or eliminated by the processing method’. 
The authors reported that no growth impairment was noted in rats fed the 
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chickpea-supplemented diet; an outcome that had been previously 
associated with legume consumption (134, 191). Concluding their report, 
Zulet et al (191) suggested that the inclusion of chickpeas in the diets of 
people with hyperlipidaemia might be beneficial in correcting their lipid profile; 
however, more investigation was required. 
 
1.3.2 Chickpeas, glycaemic response 
Legumes as a group have been shown to exhibit the lowest postprandial 
blood glucose response of several carbohydrate-containing foods in diabetic 
individuals (74). In a later study, calculation of GI of five legumes and seven 
other carbohydrate-containing foods consumed by diabetic participants, 
revealed that red lentils, with a GI of 44 ± 7 (mean ± SEM) and chickpeas 
(GI: 47 ± 9) displayed the lowest GI, compared to a mixture of white bread 
and cottage cheese – added to account for the protein content of legumes 
(73). A study investigating the glycaemic index of commonly eaten Indian 
foodstuffs found that adding chickpeas to milled rice produced the only 
significant reduction in GI, from 74 ± 8 (mean ± SEM) to 54 ± 1 (101). Other 
combinations tested included rice mixed with whole green peas, whole green 
gram, green gram dhal (dehusked and split) or red gram (pigeon pea) dhal. 
The nutrient content of the rice-chickpea mix differed from the other 
combinations mainly in the amount of total fat contained per serve – 1.5 g 
compared to 0.5 g, most of which would have been PUFA – hypothesised to 
be involved in increasing insulin sensitivity (66, 183). 
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A more recent article reported on investigations to determine whether 
ingestion of chickpeas altered postprandial and/or long-term glycaemic 
response and insulin sensitivity compared to an isoenergetic wheat-based 
diet in non-diabetic individuals (121). The postprandial study involved 19 
healthy, middle aged men and women, each consuming three standardised 
meals on three separate occasions. The meals differed only in source of 
available carbohydrate, from white bread (control), wheat or chickpea. It was 
found that plasma glucose concentrations were significantly less 30 and 60 
minutes after ingesting the chickpea meal compared to after the wheat or 
control meals. Furthermore, plasma insulin concentrations and a calculated 
measure of basal insulin resistance (Homeostasis Model Assessment of 
Insulin Resistance – HOMA-IR), measured 120 minutes post prandially, were 
both significantly lower after the chickpea meal than after the wheat or control 
meals. These results infer that legume (specifically chickpea) consumption 
contributes to improved post-prandial glycaemic response and insulin 
sensitivity in healthy participants as well as in diabetic individuals. The longer 
term, randomised crossover study involved another 19 middle aged male and 
female subjects completing two periods of controlled dietary intervention, a 
chickpea-supplemented diet and a wheat-based diet, each of six weeks 
duration. Dietary fibre intake was significantly greater during the chickpea 
intervention compared to the wheat; otherwise macronutrient intake during 
the two interventions was not significantly different. Plasma glucose and 
insulin concentrations and HOMA-IR scores either fasting or two hours after 
a glucose loading, were not significantly different following the two 
interventions. These results suggest that there was no change to long-term 
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glycaemic response or insulin sensitivity due to consumption of the chickpea-
supplemented intervention compared to the wheat. The authors cited other 
literature that supported this finding although none of the sources could give 
an explanation as to why short-term improvements did not translate to the 
longer term. However, body weight remained consistent throughout the study 
and SFA consumption was unchanged. 
 
Examination of the literature reveals a gradual development of interest in the 
role of legumes and pulses in a healthy diet and the perceived ‘anti-nutritive’ 
consequences of pulses are being countered. Animal models have provided 
proof of the hypocholesterolaemic action of legumes and their ability to 
improve glycaemic control but the results haven’t translated so successfully 
to human studies. Chickpeas are a relatively novel addition to some Western 
cuisines and currently there are very few studies in the literature examining 
the effects of chickpeas on human health, especially with regard to CVD risk 
factors such as hypercholesterolaemia, diabetes and obesity. Completed 
studies have suggested beneficial effects but results have not been 
consistent for a number of reasons. A difference in location of the studies 
provides different population study groups that may reflect different 
responses to intervention diets. The type of chickpea used in the Indian 
studies (Desi) contains more fibre and less protein than the chickpeas used 
in the Western studies (Kabuli) and the small number of participants in the 
small number of human studies prevents accumulation of a decent amount of 
data for meta-analysis. Thus additional research is required in order to 
understand better how including chickpeas in the diet may affect CVD risk 
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factors especially in Western populations. The following chapters describe 
controlled and ad libitum investigations into the effect of chickpeas on 
physiological and metabolic variables, with particular emphasis on CVD risk 
factors such as serum lipid profile, glycaemic control and body weight. 
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1.4 Aim of studies 
The aim of the studies described in the following chapters, was to investigate 
the effect of incorporating chickpeas in a typical ‘Australian-style’ diet, on 
some metabolic variables linked to CVD risk. The approach was two-fold: 
 
1. To compare the effect of a chickpea-supplemented intervention diet to an 
isoenergetic, macronutrient-matched, high-fibre wheat-supplemented 
intervention on serum lipids and lipoproteins, glycaemic control, satiation and 
bowel function. To facilitate better understanding of the physiological role of 
dietary fibre, the study also included a comparison of the effect of the wheat-
supplemented intervention diet to an isoenergetic, macronutrient matched, 
lower-fibre wheat-supplemented diet on bowel function and satiation. 
 
2. To investigate whether results obtained under the conditions of the 
controlled study would also occur under everyday conditions that were both 
more realistic and allowed observation of changes in food choice and intake. 
Observation of a group of free-living adults tracked the ways in which they 
adapted their habitual, ad libitum diet to include a minimum of four cans of 
chickpeas per week. 
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Chapter 2, a scientific paper accepted for publication, reports on the aims, 
methodology, results and discussion of the controlled intervention study. An 
account of the lipid results of part of this study formed the basis of my 
Honours thesis. Chapter 3 reports on the aims, methodology, results and 
discussion of the ad libitum study. Some repetition between the chapters is 
unavoidable, as they have been prepared as scientific papers for submission 
to peer-reviewed journals. Similarly, the format of chapters 2 and 3 differ 
slightly, to comply with requirements of the journals selected for publication. 
Chapter 4 summarises and discusses key findings common to the controlled 
and ad libitum studies as well as suggesting future directions for investigation 
of the long-term effects of chickpea consumption on CVD risk factors.  
 
Appendix 1, a scientific paper accepted for publication, reports on a larger 
collaborative study involving two centres - Launceston and Melbourne that 
included the serum lipid and lipoprotein data of the controlled dietary 
intervention study described in Chapter 2. All contributors were involved in 
study design, protocol and revision of the manuscript. The candidate 
administered the Launceston study, performed and analysed the laboratory 
and statistical data, wrote the original manuscript and edited subsequent 
versions. M.J. Ball was the investigator in charge of the Launceston group 
and approved final manuscript; I.K. Robertson was the consultant 
biostatistician; K.D.K. Ahuja assisted in collection of data from the 
Launceston group, laboratory testing and statistical analysis and P.J.Nestel 
was the investigator in charge of Melbourne group. Reference to this paper 
appears in the General Discussion (Chapter 4).  
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1.5 Design of studies 
Participants with a personal and/or family history of CVD risk factors such as 
age (>40 years), heart disease, high blood pressure or high cholesterol were 
targeted for the studies, to increase the possibility of a mildly 
hypercholesterolaemic/insulin resistant test population. Some authors have 
reported increased sensitivity to cholesterol-lowering intervention diets in 
hypercholesterolaemic individuals (5, 35, 48, 138, 175) and postulated 
enhanced response to low GI diets in hyperglycaemic individuals (121). 
 
A random crossover design with a washout period in between was chosen to 
compare the effects of the controlled intervention diets in the first study. The 
crossover design utilizes participants as their own controls, thereby reducing 
the effect of genetic variability – a confounding factor in intervention studies. 
In addition, a crossover design reduces the number of participants required 
to detect a difference in outcome - if there is one to detect. Randomly 
assigning participants to either diet initially, helps reduce bias that may 
influence the outcome of the study eg dietary compliance may be better 
during the initial dietary phase than the second, thus if diets were assigned in 
fixed sequence, some difference in results may be due to compliance, not to 
diet or carry-over. The inclusion of a wash-out period, where participants 
return to their usual diet, helps prevent any carry-over effect from the first diet 
to the next and allows any blood parameters that have been altered to return 
to pre-study levels prior to the commencement of the second dietary phase 
(96). 
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The ad libitum study followed an ordered crossover design, including two 
periods of habitual ad libitum dietary intake before and after the chickpea-
supplemented phase. When one phase of dietary comparison is the habitual 
diet of the participants, it is not possible to randomly assign dietary phases or 
include a washout period. The ordered crossover design chosen allows for 
two periods of habitual dietary phase to help control for any adjustments 
participants may make to their diet as a consequence of participating in a 
dietary study. 
 
It has been reported to take four weeks for blood lipid levels to reflect the 
effects of altered dietary intake where isocaloric conditions prevail (145, 146). 
The dietary intervention periods in the controlled and ad libitum studies were 
of at least five weeks duration. This allowed participants to acclimatize to the 
increased presence of chickpeas in their diet. The washout period in the 
controlled study was of six weeks duration. The chickpea phase of the ad 
libitum study was of 12 weeks duration to facilitate detection of potential 
change in anthropometric measures such as body weight, BMI, waist and hip 
circumference. 
 
Due to time constrains, only twelve of the twenty-one participants were able 
to commit to the third, lower-fibre wheat-based dietary phase of the controlled 
study. Again, due to time constraints, the lower-fibre dietary phase was of 
only three weeks duration and was commenced directly after the completion 
of the second phase. However, we were confident that three weeks was 
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enough time to reflect any changes to bowel function or satiation due to the 
change in dietary intervention. 
 
Four-day weighed dietary records, which included two week-end days, were 
used to determine energy intake initially and in the first and fifth week of each 
controlled dietary phase. Dietary records are more accurate than food 
frequency questionnaires for assessing dietary consumption of individuals or 
small groups (144). A pitfall of all recording of dietary intake is under 
reporting and dietary intake being affected by the act of recording (113). It 
has been reported that energy intake calculated from four-day dietary records 
is comparable to that calculated from seven-day records, when two week-end 
days are included (41). It has also been reported that calculations of energy 
intake from seven-day dietary data is not significantly different to calculations 
made using data collected daily for one year (80). During the chickpea phase 
of the ad libitum study, seven-day dietary records allowed researchers to 
analyse how consumption of chickpeas during the course of a week altered 
participants’ habitual food intake. 
 
The ‘gold standard’ method for measurement of peripheral tissue sensitivity 
to insulin is the euglycaemic insulin clamp, however the test is very invasive 
and lengthy (60). The Homeostasis Model Assessment of Insulin Resistance 
(HOMA-IR) is a validated index for calculation of basal insulin resistance (or 
peripheral tissue insulin sensitivity) (60, 107, 109) using fasting plasma 
glucose and insulin concentrations: 
HOMA-IR = fasting insulin (µIU/ml) x fasting glucose (mmol/L) / 22.5. 
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Paired t-tests are the statistical test used when comparing means of paired 
data i.e. data recorded at two different intervals (eg chickpea diet, wheat diet) 
on the same individuals. Simple paired t-test cannot be used accurately in 
this study design because of the need to adjust for the effects of diet order 
and chronological period. Multiple time points cannot be handled by a simple 
paired t-test. The number of data points should be the same and follow a 
normal distribution and statistically, the more sets of data measured, the 
greater the probability of significant results happening by chance (136, 147). 
 
Repeated measures ANOVA with robust standard error estimation goes 
some way to alleviating these problems: the method is reliable enough to 
overcome discrepancies in sample size and minor deviations in the 
distribution of the differences which may affect the appropriateness of the 
estimates of confidence intervals. There may also be deviations from the 
assumptions of the ANOVA methods based on ordinary least squares 
regression (normality of distribution, lack of heteroskedasticity and missing 
variables In addition, ANOVA allows comparison of more than two intervals 
on more than two populations. General linear modelling (GLM) is a form of 
maximum likelihood regression analysis; a means of assessing the effect of 
predictor (independent) variable/s on response (dependent) variable/s. In 
addition, ANOVA using GLM can analyse the effect of both categorical and 
continuous variables simultaneously. The effect of one predictor on one 
response is univariate analysis; the effect of many distinct predictors for each 
response is termed multivariate analysis (136, 147). Thus repeated 
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measures ANOVA using GLM was used, because it is a reliable method that 
accounts for the effect of diet order and chronological period of measurement 
of two or more dietary periods and can analyse the effect of individual 
nutritional predictor variables and combinations, on specific response 
variables such as serum TC and LDL-C.  
 
The rank order (or ordinal) data obtained from the bowel function and satiety 
questionnaires must be [measured] with other methods. We used the 
Wilcoxon’s signed rank test and Proportional Odds Modelling (POM) by 
ordinal logistic regression for repeated measures as rank order equivalents of 
paired t-test and GLM respectively. 
 
(Thank you to Dr. Iain Robertson for assisting with the statistics explanation). 
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Chapter 2 
 
Effects of a Controlled Diet Supplemented 
with Chickpeas on Serum Lipids, Glucose 
Tolerance, Satiation and Bowel Function 
 
2.1 Abstract 
Objective: To compare the effect of a diet supplemented with chickpeas to a 
wheat-based diet of similar fibre content on serum lipids, glucose tolerance, 
satiation and bowel function. A third, lower-fibre wheat diet provided further 
information on the effects of dietary fibre quantity on bowel function and 
satiation. 
Method: Twenty-seven free-living adults completed a randomised crossover 
study comprising two controlled dietary interventions each of five weeks 
duration. The chickpea diet included canned drained chickpeas, bread and 
shortbread biscuits containing 30% chickpea flour. The wheat diet included 
high-fibre wheat breakfast cereals and wholemeal bread. The diets were 
isoenergetic to the participants’ usual diet, matched for macronutrient content 
and controlled for dietary fibre. Following on from the second randomised 
intervention, a sub-group of 18 participants underwent a third, isoenergetic 
lower-fibre wheat diet that included low-fibre breakfast cereals and bread. 
Results: Repeated measures ANOVA revealed reductions in serum TC of 
0.25 mmol/L (p< 0.01) and LDL-C of 0.20 mmol/L (p=0.02) following the 
chickpea diet compared to the wheat. An unintended, significant increase in 
PUFA and corresponding decrease in MUFA consumption occurred during 
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the chickpea diet and statistical adjustment for this reduced but did not 
eliminate the effect on serum lipids. There was no significant difference in 
glycaemic control. Perceived general bowel health improved significantly 
during the chickpea diet although there was considerable individual variation. 
Some participants reported higher satiation during the chickpea diet. 
Conclusions: The small but significant decrease in serum TC and LDL-C 
during the chickpea diet compared to the equivalent fibre wheat diet was 
partly due to unintentional changes in macronutrient intake occurring 
because of chickpea ingestion. If dietary energy and macronutrients were not 
controlled, chickpea consumption might result in greater benefits via 
influence on these factors. 
 
2.2 Introduction 
Examination of the literature reveals a gradual development of interest in the 
contribution of pulses to a healthy lifestyle, as awareness of ethnic diets and 
lifestyles has grown (16, 17, 30, 40, 85). Chickpeas are a common 
component of traditional diets of Asian, Mediterranean, Arab and South 
American communities (48, 130). In contrast to most other pulses and 
cereals, chickpeas have a relatively high fat content (115, 172, 184); 
however, the fat is composed mostly of polyunsaturated fatty acids (PUFA), 
with less than 1% saturated fatty acids (SFA). Although chickpeas contain 
less carbohydrate than, for example, wheat (172), the starch contained has a 
higher amylose content (30-40% compared to 20%) (53, 121, 184) and the 
amylose has a greater degree of polymerisation (1667 glucose residues 
compared to 540) (135). This renders chickpea starch more resistant to 
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digestion in the small intestine, resulting in lower bioavailability of glucose 
(116, 121, 135) and higher availability of substrate for colonic fermentation – 
contributing to improved bowel health and synthesis of short chain fatty acids 
(53, 135).  
 
Compared to cereal grains, legumes overall are a very good source of dietary 
fibre (167, 175). Dietary fibre includes resistant starch, non-starch 
polysaccharide (cellulose, hemicellulose, pectin, gums and β-glucans), non-
digestible oligosaccharides and lignin (43, 47, 69, 103, 167). Dietary fibre can 
be differentiated into soluble (pectin, gums and β-glucans) and insoluble fibre 
(cellulose, hemicellulose, non-digestible oligosaccharides and lignin) (69, 
103, 167). While the ratio of soluble to insoluble fibre in legumes is 
comparable to grains (approximately 1:3 for both) (175) per 100g edible 
portion, chickpeas contain 17.4g total dietary fibre compared to 12.7g for 
wheat (172). 
 
Increased consumption of soluble, viscous fibre has been associated with 
decreased serum total cholesterol (TC), decreased serum low density 
lipoprotein-cholesterol (LDL-C) and inversely correlated with coronary heart 
disease (CHD) mortality rates (7, 43, 69, 90, 103, 125). The association 
between increased consumption of insoluble fibre and reduced risk of CHD is 
not as strong as with soluble fibre (125, 128). Higher consumption of dietary 
fibre, in particular resistant starch, has been associated with improved 
glycaemic control and insulin sensitivity (69, 71, 167). Dietary fibre may also 
be beneficial in the fight against obesity. It has been suggested that a state of 
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high satiation may be reached faster and last longer after ingestion of higher 
fibre foods because they are bulkier and take longer to eat than lower fibre 
foods (24, 103) and delay gastric emptying (19, 69). Increased consumption 
of dietary fibre has also been associated with improved bowel health and 
stool consistency (19, 28, 167).  
 
Even though chickpeas are a common constituent of many ethnic diets and 
are rich in PUFA and dietary fibre – resistant starch in particular, there has 
been little research into chickpeas and human health compared to other 
pulses. The focus of the current study was an investigation into the effect of 
substituting wheat-based foods with chickpeas on serum lipid profiles, long-
term glycaemic control, bowel function and satiation. The study compared the 
results of a chickpea-supplemented dietary intervention (test diet) to an 
isocaloric wheat-based intervention (control diet), both of five weeks duration. 
A small, sub-study compared the effects of a three-week, isocaloric, lower-
fibre wheat diet to that of the aforementioned wheat-based control diet, to 
evaluate the effect of amount of fibre as well as source of fibre on bowel 
health and satiation. 
 
2.3 Materials and Methods 
2.3.1 Participants 
Adults less than 70 years of age not taking medication for hyperglycaemia or 
hyperlipidaemia were invited to participate. All participants gave written 
informed consent and were free to leave the study at any time. The Northern 
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Tasmanian Health and Medical Human Research Ethics Committee 
approved the study (application no. H7142). 
 
2.3.2 Study design 
The study followed a randomised crossover design using two controlled 
dietary intervention periods – chickpea or wheat-based, each of five weeks 
duration. A washout-period of six to eight weeks separated the two dietary 
periods, during which time participants resumed their normal diet. Following 
on from the second randomised dietary phase, some participants 
commenced a third lower-fibre wheat-based dietary intervention (lower-fibre 
diet) of three weeks duration. Twelve participants agreed to have their bowel 
transit time (BTT) measured during the final week of each dietary period. 
 
2.3.3 Diet design 
Prior to commencing the study, participants weighed and recorded four days 
of ‘usual’ dietary intake, which was analysed using Foodworks 2.1 computer 
software (Xyris, Brisbane, Australia). This ‘usual’ record helped formulate 
individual isoenergetic chickpea and wheat intervention diets. The diets were 
comparable in energy, protein, carbohydrate, total fat and dietary fibre – 
except for the lower-fibre diet, which contained approximately half the 
amount of dietary fibre as the wheat. Every effort was made to maintain 
consistent consumption of type and quantity of dietary fats (oil, spread, 
cheese, milk, yoghurt, ice cream) during each phase. Four-day records of 
weighed dietary intake were analysed to determine participant nutrient intake 
for each dietary period. 
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Participants refrained from eating any foods with cholesterol-lowering claims, 
(e.g. margarine containing phytosterols), legumes (other than the chickpeas 
supplied) or foods with high fibre claims (e.g. 'fibre enriched' yogurt or fruit 
juices) and maintained their usual pattern of physical activity throughout the 
study period. 
 
Chickpea diet (test diet):  This intervention was based on the daily 
consumption of 140g of canned, drained chickpeas (Edgell 300g net weight, 
Simplot Australia) plus bread and shortbread biscuits – made with 30% 
chickpea flour.  
 
Wheat diet (control diet): This intervention was based on the daily 
consumption of wholemeal (wheat) bread and higher wheat fibre breakfast 
cereals (> 3.0g fibre /100g).  
 
Lower-fibre wheat diet: Designed to provide comparative information on 
bowel function, utilised white bread and lower wheat fibre breakfast cereals 
(< 3.0 g/100 g). 
 
2.3.4 Questionnaires 
Participants completed questionnaires concerning stool consistency, bowel 
function and satiation after the first and final week of each dietary 
intervention. Visual analogue scales (150 mm) anchored with descriptors 
aided assessment of frequency and ease of defecation, frequency of 
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flatulence, perceived bowel health and satiation. To determine stool 
consistency, participants referred to the Bristol Stool Form Scale (93). 
 
2.3.5 Laboratory measurements  
Collection of venous blood samples followed overnight fasting for ten hours. 
Serum and plasma aliquots were stored at -70 °C until analysis. Serum TC, 
triacylglycerols, high-density lipoprotein cholesterol (HDL-C) and plasma 
glucose were assayed in the same run for each participant, using an RA 
1000 auto analyser (Technicon, USA) and Thermotrace reagents (Thermo 
Electron Corporation, USA). Friedewald’s equation was used to calculate 
LDL-C (45). Serum insulin was measured using Insulin Radioimmunoassay 
Kits (Diagnostic Systems Laboratories Inc., Australia) and an LKB multi 
gamma counter plus RiaCalc software (Version 3). The homeostasis 
assessment model of insulin resistance (HOMA-IR) equation was used to 
calculate basal insulin resistance (107): 
HOMA-IR = fasting insulin (µIU/ml) x fasting glucose (mmol/L) / 22.5. 
 
2.3.6 Bowel transit time (BTT) 
Twelve consenting participants received gelatine capsules containing radio-
opaque markers of different sizes and shapes. Ingestion of the markers and 
subsequent collection of the faecal samples used to ascertain BTT, occurred 
in the final week of each dietary period. Examination by x-ray determined the 
number and shape of radio-opaque markers present in each sample. 
Calculation of bowel transit time utilised the following equation (133): 
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BTT = t1s1 + t2s2 + t3s3  t1, t2, t3 time of ingestion of each  
              s1 + s2 + s3    capsule 
s1, s2, s3 number of each marker present 
 
2.3.7 Statistical Analysis 
STATA Statistical Data Analysis, version 8.2 (STATA 8.2 Statacorp, USA) 
was used for statistical analysis. Repeated measures ANOVA using General 
Linear Modelling (GLM) was used to compare results for each of the diets 
and to examine the effect of diet and dietary components on serum lipid 
profile and glucose tolerance. Answers from the questionnaires were 
analysed using Wilcoxon’s Signed Rank Test for non-parametric data. 
 
2.4 Results 
2.4.1 Subject description 
Thirty-one participants commenced the first, randomly assigned, intervention 
period – either chickpea- or wheat-based. Four participants failed to complete 
both the diets, three due to employment commitments and one due to 
discomfort attributed to chickpea consumption. The mean age (± SD) of the 
remaining twenty-seven participants (7 pre-menopausal and 10 post-
menopausal women and 10 men) was 50.6 ± 10.5 years and BMI 28.8 ± 4.4 
m/kg². The mean fat content of their ‘usual’ diets was 87.7 ± 28.3 g/day (33% 
of energy - %E). The mean proportion of SFA was 44 ± 7 % of total fat 
consumed (%TF), 17 ± 6 %TF PUFA and 39 ± 4 %TF monounsaturated fatty 
acids (MUFA). The amount of dietary fibre consumed was 27.9 ± 7.1 g/day 
with 48% provided by the cereal food group, 26% from vegetables, 19% from 
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fruit and 7% from nuts and legumes. Eighteen participants (2 pre 
menopausal and 9 postmenopausal women and 7 men) agreed to undergo 
the third, low-fibre wheat diet during which they consumed 15.2 ± 1.60 grams 
of fibre per day, from the same food sources as above but using lower fibre 
choices. 
Table 2.1 Comparison of nutritional intake and bodyweight at the end of the 
dietary periods 1, 2 
Dietary periods  
Wheat Chickpea 
Body weight (kg) 83.8 (77.3 to 90.4) 83.9 (77.4 to 90.4) 
Total energy consumed (MJ/day) 9.08 (8.48 to 9.69) 8.89 (8.35 to 9.42) 
Protein (%E)3 18.2 (17.0 to 19.5) a 17.2 (16.1 to 18.2)b 
Carbohydrate (%E) 42.6 (40.5 to 44.6) 43.6 (41.4 to 45.8) 
Total fat (%E) 34.0 (32.1 to 36.0) 33.9 (31.8 to 35.9) 
Saturated fat (%TF)3 40.4 (37.5 to 43.2) 40.5 (37.2 to 43.8) 
Polyunsaturated fat (%TF) 14.7 (13.4 to 16.0) a 17.6 (15.7 to 19.4) b
Monounsaturated fat (%TF) 45.0 (42.6 to 47.4) a 42.0 (38.8 to 45.1) b
Dietary fibre (g/day) 29.3 (26.3 to 32.2) 28.4 (26.4 to 30.5) 
 
1 Values are mean (95% Confidence Interval) 
2 n=27 
3 Values expressed as a percentage of energy (%E) or as a percentage of total fat (%TF) 
consumed 
a or b Different superscripts denote significant difference (p<0.05) (repeated measures 
analysis of variance using general linear modelling) 
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2.4.2 Nutrient content of diets 
During the chickpea intervention, chickpea based foods contributed 
approximately 2.4 MJ of energy per day from protein (17%E), total fat 
(22%E), carbohydrate (61%E) and approximately 15g of dietary fibre. During 
the wheat intervention, wheat based foods contributed approximately 2.6 MJ 
of energy per day from protein (14%E), total fat (16%E), carbohydrate 
(70%E) and approximately 17g of dietary fibre. 
 
Table 2.1 shows the mean nutrient intake as recorded by study participants 
in the final week of the chickpea- and wheat-based diets. Similarity in body 
weight at the end of each diet suggests total macronutrient intake was 
comparable. There was a significant decrease in mean consumption of 
protein, as a percentage of energy consumed, during the chickpea diet even 
though the difference was only one percent of energy consumed (p=0.04). 
This difference was due to substitution of meat-group foods with chickpeas 
during the chickpea phase. The mean intake of protein contributed by meat, 
fish, poultry or eggs was 89 g/day (28%) compared to 140 g/day (40%) 
during the wheat diet. Analysis of the background diets of the participants 
during each intervention i.e. nutrient intake apart from wheat or chickpea-
based foods (Table 2.2), also showed a significant decrease in consumption 
of protein (%E) with a corresponding increase in carbohydrate consumption 
during the chickpea diet compared to the wheat (p=0.001). Otherwise the 
background diets of the participants during the interventions were 
comparable.  
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Total fat consumption was similar during the intervention diets, as designed; 
however, fatty acid consumption was unexpectedly, significantly different. 
Participants consumed significantly more polyunsaturated fatty acids (PUFA) 
during the chickpea diet compared to the wheat (p<0.01) and less 
monounsaturated fatty acids (MUFA) (p=0.03). 
 
Table 2.2 Comparison of background nutritional intake (apart from chickpea 
and wheat products) at the end of the dietary periods 1, 2 
Dietary periods 
 
Wheat Chickpea 
Total energy consumed (MJ/day) 6.6 (5.91 to 7.25) 6.4 (5.83 to 6.96) 
Protein (%E)3 20.1 (18.4 to 21.9) a 17.3 (15.7 to 18.8) b
Carbohydrate (%E) 35.5 (32.2 to 38.8) a 39.3 (36.3 to 42.4) b
Total fat (%E) 39.4 (36.6 to 42.1) 38.4 (35.8 to 40.9) 
Saturated fat (%TF)3 40.4 ( 37.5 to 43.3) 40.2 (36.6 to 43.9) 
Polyunsaturated fat (%TF) 12.8 ( 11.1 to 14.5) 14.2 (12.2 to 16.2) 
Monounsaturated fat (%TF) 46.8 (44.4 to 49.1) 45.6 (41.8 to 49.3) 
Dietary fibre (g/day) 13.3 ( 10.8 to 15.9 12.4 (10.8 to 14.1) 
1 Values are mean (95% Confidence Interval)    2 n=27 
3 Values expressed as a percentage of energy (%E) or as a percentage of total fat (%TF) 
consumed per day 
a or b Different superscripts denote significant difference (p<0.05) (repeated measures 
analysis of variance using general linear modelling) 
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2.4.3 Effect of chickpea diet on serum lipids and glycaemic response 
Table 2.3 shows the results of serum lipid profiles, glucose, insulin and 
insulin resistance (HOMA-IR score), for the chickpea- and wheat-based diets, 
adjusted for order of diet and chronological period of measurement. There 
was a significant reduction in mean serum TC of 0.25 mmol/L (p< 0.01) and 
LDL-C of 0.20 mmol/L (p=0.02) during the chickpea diet compared to the 
wheat. Results for glucose, insulin and HOMA-IR were not significantly 
different. 
Table 2.3 Comparison of results for each dietary intervention phase 1, 2 
 Wheat Chickpea 
Bowel transit time (hrs) 3 41.7 (29.0 to 54.5) a 52.3 (39.0 to 65.7) b 
TC (mmol/L) 4 6.13 (5.62 to 6.65) a 5.88 (5.36 to 6.39) b 
LDL-C (mmol/L) 4 4.09 (3.65 to 4.52) a 3.89 (3.45 to 4.33) b 
HDL-C (mmol/L) 4 1.36 (1.21 to 1.50) 1.33 (1.19 to 1.47) 
Triacylglycerols (mmol/L) 4 1.53 (1.31 to 1.75) 1.44 (1.14 to 1.75) 
Glucose (mmol/L) 4 5.33 (5.04 to 5.62) 5.26 (5.02 to 5.51) 
Insulin (µU/ml) 4 9.33 (6.89 to 11.77) 9.87 (7.38 to 12.35) 
HOMA-IR4, 6 2.23 (1.54 to 2.92) 2.33 (1.68 to 3.00) 
 Wheat Low fibre wheat 
Bowel transit time (hrs) 5 39.9 (27.3 to 52.5) a 48.7 (29.5 to 68.0) b 
¹ Values adjusted for order of diet and chronological order of measurement 
2 Values are mean (95% Confidence Interval) 3 n=12  4 n=27  5 n=10 
6 Homeostasis Model of Assessment of Insulin Resistance 
a or b Different superscripts denote significant difference (p<0.05) 
(repeated measures analysis of variance using general linear modelling) 
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Univariate analysis (adjusted for order of diet and chronological period of 
measurement) suggested that PUFA and MUFA were the dietary 
components that produced the greatest singular effect on serum TC and 
LDL-C. With each increase in standard deviation of PUFA ingested, mean 
serum TC reduced by 0.29 mmol/L and LDL-C by 0.24 mmol/L. Conversely, 
with each increase in standard deviation of MUFA ingested, mean serum TC 
increased by 0.20mmol/L and LDL-C by 0.13 mmol/L. Dietary fibre had only a 
marginal effect, with mean serum TC and LDL-C both reduced by 0.04 
mmol/L for every increase in standard deviation of dietary fibre.  
 
The diets were then classified into those components that the subjects were 
advised to include in their diet in order to create the differences between the 
diets (the chickpea- and wheat-based foods), and those components that 
were common to both diets (the background diets). The effect of the chickpea 
versus the wheat diet was again compared, this time after adjustment of the 
common diet for PUFA and fibre content. The difference in mean serum TC 
was reduced on the chickpea diet from 0.25 mmol/L (p<0.01) to 0.12 mmol/L 
(p=0.18) and mean LDL-C from 0.20mmol/L (p=0.02) to 0.07 mmol/L 
(p=0.27) by adjustment for PUFA. The singular effect of PUFA on serum TC 
and LDL-C was again much greater than the effect of dietary fibre. This time, 
one standard deviation increase in PUFA was associated with a mean 
decrease in serum LDL-C of 0.26mmol/L, compared to a mean decrease of 
0.05 mmol/L for one standard deviation increase in dietary fibre. 
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2.4.4 Effect of diet on BTT and appreciation of bowel function by 
participants  
Table 2.3 also shows the results of BTT for the intervention diets, adjusted 
for order of diet and chronological period of measurement. For the chickpea-
wheat comparison, results for eight of the 12 participants showed very little 
difference in BTT due to diet, while results for four individuals were markedly 
longer during the chickpea diet compared to the wheat. Consequently, the 
mean BTT was 10.6 hrs longer during the chickpea diet compared to the 
wheat (p=0.02). For the higher-lower wheat fibre comparison, the mean BTT 
was 8.8 hrs longer during the lower-wheat fibre diet compared to the higher 
(p=0.03), with the majority of participants showing a longer BTT during the 
lower-wheat fibre dietary period. Figure 2.1 demonstrates the wide variability 
of results from participants who underwent a BTT during each of the three 
dietary periods.  
Fig 2 1. Comparison of bowel transit times between the chickpea, wheat and 
low-fibre wheat diets for each participant (n=10) 
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The questionnaire responses for the chickpea-wheat comparison showed a 
great deal of variation and thus fewer significant differences were detected. 
During the chickpea diet, participants recorded a variety of effects on stool 
consistency in week one (hard to mushy) which resolved to smooth and soft 
by week five. There was a slight trend in defecation becoming easier during 
the course of both diets while frequency of defecation increased slightly 
during the wheat diet and decreased slightly during the chickpea diet. Just 
under half the respondents noticed an initial increase in the frequency of 
flatulence for both diets, the remainder reporting no change. Perceived bowel 
health was initially significantly better during the chickpea diet compared to 
the wheat (chickpea vs. wheat week 1; p=0.04) and improved significantly 
over the course of the chickpea diet (chickpea week 1 vs. chickpea week 5; 
p=0.04). One individual (dashed line) reported ‘terrible’ bowel health 
throughout the wheat diet compared with ‘much better’ health during the 
chickpea phase. Even so, there was no significant difference in perceived 
bowel health between the chickpea and wheat diets in week 5, due to the 
wide variation in individual responses. The degree of satiation reported by 
the group was high throughout both the dietary periods. 
 
For the higher-lower wheat fibre subgroup comparison, participants recorded 
a variety of effects on stool consistency (hard to mushy) throughout each of 
the dietary periods. There were no significant differences detected in 
frequency of defecation or perceived bowel health – the participant who 
reported ‘terrible’ bowel health during the wheat phase of the chickpea-wheat 
comparison did not undertake the lower-fibre wheat diet. Ease of defecation 
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was slightly reduced from usual during the lower-fibre wheat diet and 
marginally easier during the higher-fibre wheat but no significant difference 
was detected (p=0.06). Frequency of flatulence on the other hand, was 
reported as significantly greater during the higher-fibre wheat diet in week 5 
(p=0.02). While the degree of satiation did not alter during the lower-fibre 
wheat diet, again, satiation was significantly higher during the higher-fibre 
wheat diet, after both one and five weeks (p≤0.01). 
 
2.5 Discussion 
Significant reductions in serum TC and LDL-C followed five weeks 
consumption of a chickpea-supplemented test diet compared to a wheat-
based control diet of similar dietary fibre content. Statistical analysis 
suggested that an unanticipated change in fatty acid composition during the 
chickpea diet (particularly PUFA) was related to the reductions in serum TC 
and LDL-C. Adjusting the data to take account of the effect of PUFA 
substantially reduced, but did not abolish, the difference in serum TC and 
LDL-C between the chickpea and wheat diets. This suggests some other 
component or components of chickpeas were responsible for 40% of the 
effect of the chickpea diet on serum TC and LDL-C. A meta-analysis 
investigating the hypocholesterolaemic effect of non-soy pulses on serum 
lipids (9) concluded that while soluble dietary fibre contributed the greatest 
effect, other factors such as oligosaccharides, isoflavones, phospholipids and 
fatty acids, phytosterols, saponins, other vitamins and minerals also played 
an important role.  Even so, the authors concluded it was the sum of the 
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whole rather than individual components that were responsible for the 
hypocholesterolaemic effect of pulses. 
 
The absence of observed effect of dietary fibre on serum TC and LDL-C may 
have been due to the similar dietary fibre content of the chickpea and wheat 
diets (28.73 vs. 27.86 g/day) coupled with the similar ratio of soluble to 
insoluble fibre present in chickpeas and wheat. Furthermore, the dietary fibre 
intake during the chickpea and wheat diets was very similar to the mean 
‘usual’ intake of this group of participants (27.9 ± 7.1 g/day). While a number 
of studies have investigated the effect of high fibre in addition to other dietary 
components on glucose tolerance and hyperlipidaemia (6, 11, 46, 155) (99) 
(127) only a few have investigated the effect of high dietary fibre intake alone 
(26). All of these studies compared intervention diets containing at least two 
to three times more dietary fibre (primarily insoluble fibre) than the control or 
usual diet - in some cases, five or six times greater (11, 46, 155). It has been 
suggested that cholesterol-lowering by high fibre diets is best observed in 
studies where the dietary fibre intake is very high (25), as much as two to 
three times the recommended intake (138). In the current study, the focus 
was to compare the effect of source of dietary fibre rather than quantity. 
Thus, the chickpea and wheat intervention diets contained a realistic amount 
of dietary fibre, consistent with recommended dietary guidelines (37), rather 
than an extreme amount that participants may have found difficult to 
consume; potentially affecting compliance. 
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The chickpea intervention did not have any significant effect on glucose 
tolerance or insulin sensitivity compared to the wheat diet, even though 
chickpeas contain more resistant starch than wheat. However alterations in 
dietary fatty acid content between the intervention diets involved adjustment 
to the PUFA:MUFA ratio; the P:S ratio remained unaffected. Research 
suggests substitution of unsaturated fatty acids for SFA may improve insulin 
sensitivity (66, 67, 148, 183), so substitution of PUFA for MUFA may not be 
expected to cause any change. Another controlled, dietary intervention study 
(121) also reported no change in fasting plasma glucose, insulin 
concentrations or HOMA-IR after six weeks of chickpea-supplemented 
intervention compared to wheat, even though post-prandial results showed 
reduced plasma glucose and insulin responses following ingestion of a 
chickpea-based meal compared to a wheat meal. The authors postulated that 
the normoglycaemic state of their participant population (5.2 ± 0.4 mmol/L, 
n=19) might have contributed to the apparent lack of long-term improvement 
in glucose tolerance. The participant population for the current study would 
also be considered normoglycaemic, with mean fasting glucose levels below 
6.0 mmol/L and insulin concentrations of less than 30 µIU/ml (39). 
Furthermore, in both the current study and that of Nestel et al (121) there 
was no significant weight loss during the dietary intervention periods and 
there was no change in the P:M:S ratio of the intervention diets of Nestel et al 
(121). 
 
The current study also surveyed the bowel function and perceived bowel 
health of participants during the dietary periods. The results suggest that 
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increased consumption of chickpeas would not adversely affect bowel 
function compared to increased consumption of wheat. It may prove 
beneficial for gluten-sensitive individuals looking for alternatives to increase 
their dietary fibre content. Flatulence has generally been associated with 
ingestion of pulses (36) but in this study, although a significant reduction in 
frequency of flatulence was detected in the subgroup during the lower-fibre 
wheat phase, there was no difference between the chickpea and wheat diets. 
Chickpeas should thus not be deemed unacceptable for this reason. The 
canning process and further cooking by participants could have reduced the 
oligosaccharide activity (and thus degree of flatulence) of the chickpeas.  
 
Research generally supports an inverse relationship between fibre content of 
the diet and BTT (19, 28, 167). However, focus on the effect of particular 
fibre sources is not as clear-cut. Addition of wheat bran to the diet has been 
shown to reduce BTT but this effect may be due to the physical form of the 
wheat bran used rather than a particular constituent (25, 28, 92, 170). Other 
studies have reported no change in BTT after ingestion of wheat bran or 
pectin (161), oat hull fibre (162) or green lentils (163). It has also been 
suggested that one of the physiological effects of resistant starch is a 
tendency to increase BTT rather than reducing it (117) Dietary fibre 
consumption is one of many variables that influence colonic function. Other 
variables include gender, age, stress, hormones, hydration and the 
absorptive function of the small intestine (28). Even though in the current 
study both the chickpea and lower-fibre BTT’s were significantly longer than 
during the control wheat diet, they were still within the normal range of 1-4 
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days (24–96 hrs) (28). Thus, any difference is difficult to interpret and may 
just highlight the variation in individual response to dietary change. 
 
The majority of participants had no trouble adjusting to the chickpea diet and 
there was high acceptance of both the chickpea bread and shortbread 
biscuits. Most appetites were satisfied during the chickpea and wheat diets. 
The significant reduction in satiation noted during the lower-wheat fibre 
phase may have been due to an unplanned reduction in energy consumption 
during this intervention where, to keep dietary fibre to a minimum, 
participants consumed white rice rather than pasta or potato along with lower 
fibre fruit and vegetables. Some participants commented that during the 
chickpea diet they no longer 'craved' the sweet and fatty 'treats' to which they 
were normally 'addicted'. This fits with comments to the American Dietetics 
Association that the less quantifiable effects of dietary fibre such as satiation 
are just as important as the statistically significant effects of fibre 
consumption (103).  
 
2.6 Conclusion 
Substitution of chickpeas for wheat-based foods in a controlled dietary 
intervention resulted in small but significant reductions in serum TC and LDL-
C that were partly due to changes in fatty acid content. Chickpeas as a whole 
may have contributed a small benefit - both in their own right and/or through 
dietary substitution. Chickpeas are rich in PUFA and may have provided 
improvements related to this. In addition, inclusion of chickpeas may have 
caused other beneficial physiological and dietary changes associated with 
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increased satiation. These aspects need to be explored in studies that do not 
attempt to control the overall macronutrient or non-chickpea fibre content of 
the intervention diets, as this study indicates that more beneficial 
physiological and biochemical changes may result via this mechanism. 
 
 69
Chapter 3 
 
Chickpeas influence P:S ratio and fibre 
content of ad libitum dietary intake leading to 
improved serum lipid profile, glycaemic control 
and satiation. 
 
 
3.1 Abstract 
Objective To estimate the effect of including a realistic quantity of chickpeas 
in an otherwise ad libitum diet of free-living adults. 
Design Ordered crossover design of 20 weeks duration. 
Subjects Forty-five adult women and men, as a group slightly 
hypercholesterolaemic but normoglycaemic. 
Intervention Participants included a minimum of four, 300 g cans of 
chickpeas per week in their habitual diet for twelve weeks. 
Main outcome measures Comparison of macronutrient and dietary fibre 
consumption, body weight, body mass index, fasting plasma glucose, serum 
lipids, lipoproteins, insulin, leptin and ghrelin concentrations, after habitual 
diet supplemented with chickpeas and after four weeks of post chickpea ad 
libitum diet. Semi-quantitative assessment of bowel function and satiation 
using anchored visual analogue scales. 
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Statistical analyses Repeated measures ANOVA using General Linear 
Modelling (GLM) with robust standard error estimation. Ordinal logistic 
regression for ordinal data. 
Results Chickpea-related increases in mean dietary fibre and 
polyunsaturated fatty acids intake were associated with decreases in serum 
total and low-density lipoprotein cholesterol, fasting insulin and HOMA-IR 
when compared to the usual dietary phase. Small but significant reductions in 
body weight with increased perceived satiation and improved bowel function 
were noted during the chickpea phase compared to the usual dietary phase. 
Conclusions Adding chickpeas to the diet is an option for individuals 
wanting to modify their diet associated CVD risk factors. 
 
3.2 Introduction 
The association between diet and cardiovascular disease (CVD) is well 
known (1, 2, 66, 110, 143). Any uncertainty concerns the choice of 
replacement macronutrient/s for dietary saturated fatty acids (SFA) that will 
achieve optimal glycaemic control and blood lipid concentrations and thus 
greatest reduction in CVD risk (66, 143). Candidate macronutrients include 
poly- and monounsaturated fatty acids (PUFA & MUFA), high-fibre 
wholegrain carbohydrates and plant proteins. In addition to CVD, obesity is 
associated with hypertension, insulin resistance, non-insulin dependent 
diabetes mellitus, sleep apnoea, (84) some cancers, osteoarthritis, gall 
bladder disease (178) gout, mood and eating disorders (20, 55). Modest 
weight loss (∼10%) has been shown to improve glycaemic response, insulin 
sensitivity and lipid profile (58, 59, 82, 102, 173, 174). Advances in 
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understanding the metabolic interactions that govern energy balance, 
appetite and body weight have fuelled increased interest in the effect of diet 
and dietary constituents on satiation (degree of fullness leading to meal 
cessation), satiety (interval between cessation of one meal and initiation of 
the next) (62, 137, 188) and biomarkers of energy regulation such as leptin 
and ghrelin (31, 137, 158). Some researchers suggest diets rich in complex 
carbohydrate (dietary fibre) and low in fat have a greater satiating effect than 
diets high fat and low in carbohydrate (61, 158, 188) and thereby contribute 
to reduced energy consumption and weight loss. It has been suggested that 
satiation may be reached faster and satiety last longer after ingestion of 
higher-fibre, complex carbohydrate-containing foods because they are bulkier 
and take longer to eat than lower fibre foods (63, 103) and delay gastric 
emptying (19, 63, 69). Both ghrelin, an appetite stimulant strongly associated 
with hunger ratings and satiety and leptin, an appetite suppressant 
associated with long-term energy balance, are more strongly affected by 
dietary carbohydrate than dietary fat (31). Increased consumption of higher 
fibre foods has also been associated with improved bowel health and stool 
consistency (29). (28, 167). 
 
Chickpeas are a rich source of unsaturated fatty acids – particularly PUFA 
(115, 172, 184), resistant starch (53, 121, 184), dietary fibre (172) vitamins 
(51), minerals (114, 129) and phytoestrogens (108, 118, 149, 151, 154).  
They are relatively free of antinutrients, such as lectins, but do contain small 
amounts of saponins, some tannins and phytate (51, 129, 134). 
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Previous controlled dietary intervention studies performed by the current 
authors (Appendix 1 and Chapter 2), suggested that isoenergetic chickpea 
supplementation of an equivalent-fibre wheat-based ‘Australian’ style diet, 
brought about increased PUFA consumption that was related to small but 
significant reductions in serum low-density lipoprotein (LDL) and total 
cholesterol (TC) concentrations, in mildly hypercholesterolaemic women and 
men. However, macronutrient control of the diets could have reduced the 
impact of chickpea consumption. The purpose of the current study was to 
observe the effects of chickpea supplementation on ad libitum nutrient intake, 
serum lipids, lipoproteins and other metabolic and physiological changes in a 
more realistic setting. Apart from consumption of a minimum amount of 
canned chickpeas per week for 12 weeks, participants were under no other 
dietary constraints.  
 
3.3 Method 
3.3.1 Participants 
Adults aged of 30 and 70 years, not on medication to control hyperglycaemia 
or hyperlipidaemia, were recruited via the local media. Criteria for acceptance 
into the study included the presence of one or more cardiovascular disease 
(CVD) risk factors likely to result in dyslipidaemia or poor glucose tolerance 
(e.g. elevated serum total cholesterol, overweight, older age) and/or a family 
history of heart disease, non-insulin dependent diabetes or CVD risk factors. 
Participants gave written informed consent and were free to leave the study 
at any time. The Northern Tasmanian Health and Medical Human Research 
Ethics Committee granted approval for the study (application no. H0007926). 
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3.3.2 Study design 
Participants commenced the dietary phases in an ordered crossover fashion, 
beginning with a four-week period of their habitual ad libitum dietary intake 
(familiarisation phase), followed by twelve weeks of ad libitum dietary intake 
including chickpeas (chickpea phase) and then a second four week phase of 
their habitual ad libitum dietary intake (usual phase). When one phase of 
dietary comparison is the habitual diet of the participants, it is not possible to 
blind the dietary phases or randomly assign them. The ordered crossover 
design chosen allows for two periods of habitual dietary phase to help control 
for any adjustments participants may make to their diet as a consequence of 
participating in a dietary study. Twelve weeks of chickpea inclusion allowed 
for longer-term observation of possible dietary change and incremental 
change in body weight. Time considerations prevented a 12-week usual 
phase being practical and a four-week phase allowed sufficient time for 
observation of any metabolic changes. 
 
Using Terraillon ‘Café Inox’ food-weighing scales (2 g), supplied for the 
study, .participants weighed and recorded their dietary intake during the final 
week of each dietary phase and half way through the chickpea phase. 
Analysis of these records checked compliance with chickpea consumption 
and determined nutrient consumption during the chickpea and usual phases. 
This helped to determine which foods the chickpeas were replacing. 
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The participants completed questionnaires concerning stool consistency, 
bowel function and satiation during the final week of the chickpea and usual 
phases and at the midpoint of the chickpea phase. Visual analogue scales 
(150 mm) anchored with descriptors aided assessment of frequency and 
ease of defecation, frequency of flatulence, perceived bowel health and 
satiation. To determine stool consistency, participants referred to the Bristol 
Stool Form Scale (93). 
 
3.3.3 Diet design 
During the familiarisation and usual phases, participants were requested to 
consume their habitual ad libitum dietary intake. During the chickpea phase 
participants were required to incorporate a minimum of four, 300 g (net 
weight) cans of chickpeas (Edgell, Simplot, Australia) per week into their ad 
libitum diet. Per 100 g, the chickpeas provided 0.47 MJ of energy, 14.8 g of 
carbohydrate, 6.8 g of protein, 1.2 g of total fat – 0.3 g SFA, 0.7 g MUFA, 0.8 
g PUFA, 6.9 g of dietary fibre – 6.2 g insoluble and 0.7 g soluble. The 
researchers provided the cans, and a selection of recipes - to equip 
participants with a variety of alternatives for chickpea consumption. No 
advice was given to the participants regarding chickpea food exchange; they 
were allowed to make their own adjustments, as one of the aims of the study 
was observing the effect of chickpea supplementation on ad libitum nutrient 
intake. 
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3.3.4 Laboratory measurements  
Collection of venous blood samples followed ten hours of overnight fasting. 
Samples for serum collection were stored at room temperature until 
coagulation and clot retraction had occurred; samples for plasma isolation 
were stored on ice until separation. Serum and plasma aliquots were 
obtained by centrifugation at 4 ºC for 20 minutes at 2500 rpm. Aliquots were 
stored at -70 °C. Prior to testing, the serum samples were thawed at room 
temperature and thoroughly mixed. 
 
Serum TC, triacylglycerols, high-density lipoprotein cholesterol (HDL-C) and 
plasma glucose were assayed in the same runs for each participant to 
reduce the inter-assay variability, using a DataPro Clinical Analyser (Thermo 
Trace Ltd, USA) and Thermotrace reagent kits (Thermo Trace Ltd, USA). 
Mean laboratory intra-assay precision for plasma glucose, serum TC, 
triacylglycerols and HDL-C was 1.9%, 2.1%, 2.3% and 5.1% respectively. 
Friedewald’s equation (45) was used to calculate serum LDL-C and the 
homeostasis assessment model of insulin resistance (HOMA-IR) equation 
(107) was used to calculate basal insulin resistance (peripheral tissue insulin 
sensitivity): 
HOMA-IR = fasting insulin (µU/ml) x fasting glucose (mmol/L) / 22.5. 
 
Serum insulin was measured using Insulin Radioimmunoassay Kits 
(Diagnostic Systems Laboratories Inc., Texas, USA); serum leptin was 
measured using Active Human Leptin Immunoradiometric Assay Kits 
(Diagnostic Systems Laboratories Inc., Texas, USA); serum total ghrelin was 
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measured using Ghrelin (total) Radio Immunoassay kits (LINCO Research, 
Missouri, USA) and an LKB multi gamma counter plus RiaCalc software 
(Version 3). The sensitivity of the methods at the 95% confidence level was 
1.3 µIU/ml for insulin, 10 ng/ml for leptin and 93 ρg/ml for ghrelin, according 
to information supplied with the reagent kits. Intra-assay coefficients of 
variation for serum insulin, leptin and ghrelin were 8.0%, 2.1% and 5.6% 
respectively. 
 
3.3.5 Statistical analysis 
Sample size calculation based on previous studies in similar populations (13) 
indicated that 45 subjects would be required to detect a 5% reduction in total 
cholesterol concentration using a cross-over design (standard deviation of 
change in cholesterol of 0.9 mmol/L, power 80%, alpha 0.05). STATA 
Statistical Data Analysis, version 8.2 (Statacorp, USA) was used to analyse 
the data. Repeated measures ANOVA using General Linear Modelling (GLM) 
with robust standard error estimation was used to examine the effect of diet 
and dietary components on serum lipid profile and glycaemic control. 
Responses to the bowel function and satiation questionnaires were analysed 
using Proportional Odds Modelling (POM) by ordinal logistic regression for 
repeated measures ordinal outcome data. 
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3.4 Results 
3.4.1 Effect of Chickpea supplementation on dietary constituents, 
physiological and anthropomorphic measures 
Fifty participants commenced the familiarisation phase of the study (34 
females, 16 males). One male withdrew during this initial phase due to work 
commitments; two withdrew after six weeks of the chickpea phase, one due 
to health problems unrelated to chickpea consumption and another following 
an adverse reaction to venipuncture. Two females withdrew after six weeks 
of the chickpea phase, one due to health problems not related to chickpea 
consumption and one due to a surfeit of chickpeas. The baseline 
characteristics of the 45 participants who completed the twenty-week study 
(32 females, 13 males) are contained in Table 3.1. The group was mildly 
hypercholesterolaemic but normoglycaemic. 
 
Table 3.2 compares the mean daily macronutrient and dietary fibre intake of 
the participants during the final week of each of the dietary periods: the 
familiarisation phase - just prior to the inclusion of chickpeas in their diets; the 
chickpea phase – after 16 weeks of including chickpeas in their diet and the 
usual phase, four weeks after the participants had returned to their habitual 
ad libitum diet. Statistically significant alterations in dietary intake during the 
familiarisation and usual phases compared to the chickpea phase are 
indicated by differing superscripts. These differences are more clearly 
illustrated in table 3.3.
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Table 3.1. Baseline characteristics of the study participants ¹ 
  Mean ± sd 
Age years 52.2 ± 6.09 
Weight kg 74.7 ± 16.0 
Body Mass Index kg/m² 26.3 ± 4.82 
Waist Hip Ratio ratio 0.84 ± 0.09 
Total Cholesterol mmol/L 6.51± 1.39 
HDL-Cholesterol mmol/L 1.68 ± 0.39 
LDL-Cholesterol mmol/L 4.10 ± 1.05 
Triacylglycerols mmol/L 1.52 ± 1.11 
TC:HDL ratio 4.02 ± 0.97 
HDL:LDL ratio 0.44 ± 0.15 
Glucose mmol/L 4.95 ± 1.00 
Insulin µIU/ml 6.25 ± 4.29 
HOMA-IR 2  1.45 ± 1.34 
 
1 n=45 
2 Homeostasis model assessment of insulin resistance, a mathematical model of basal 
insulin sensitivity, derived from fasting glucose and fasting insulin concentrations. 
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Table 3.2 Dietary intake during the final week of the familiarisation, chickpea and usual dietary phases1,  
Familiarisation phase Chickpea phase Usual phase 
 
Mean ± sd Mean ± sd Mean ± sd 
Dietary fibre g 24.31 ± 7.77 b 28.60 ± 6.97 a 21.83 ± 8.19 b 
Total energy mJ 7.87 ± 1.60  7.85 ± 2.11 7.63 ± 1.81  
Protein %E 18.28 ± 2.93 a 18.44 ± 3.26 a 17.54 ± 2.45 b 
Carbohydrate %E 46.97 ± 7.72 46.73 ± 5.79 46.61 ± 6.55 
Total fat %E 29.71 ± 5.63 a 29.75 ± 5.68 a 31.36 ± 6.02 b 
Sfa2 %TF 42.53 ± 6.11 a 41.56 ± 6.33 a 44.70 ± 7.84 b 
Pufa3 %TF 16.87 ± 4.41 b 18.30 ± 4.35 a 15.64 ± 5.29 b 
Mufa4 %TF 40.60 ± 3.58 40.14 ± 3.53 39.67 ± 4.19 
P:S ratio ratio 0.42 ± 0.18 b 0.47 ± 0.19 a 0.39 ± 0.26 b 
1N=42 
2 Saturated Fatty Acids 
3 Polyunsaturated Fatty Acids 
5 Monounsaturated Fatty Acids 
a b Different superscripts denotes a significant difference compared to the chickpea phase, p<0.05 (repeated measures ANOVA using  
         general linear modelling) 
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Table 3.3 shows the mean differences in quantity of dietary fibre, 
macronutrients and fatty acids consumed in the first and final weeks of the 
chickpea and usual phases. Mean dietary fibre intake was increased by 4.30 
g/day (95% CI: 2.91 g/day to 5.69 g/day, p<0.001) during the chickpea 
phase. There was also a significant increase in mean PUFA consumption of 
1.43% of total fat (95% CI: 0.28 %TF to 2.58 %TF, p=0.02), which coupled 
with a small decrease in mean saturated fatty acid (SFA) consumption, 
caused the P:S ratio to significantly increase during the chickpea phase by 
0.05 (95% CI: 0.00 to 0.09, p=0.045). During the usual phase mean PUFA 
consumption decreased by 2.66 %TF (95% CI:  
-4.35 %TF to -0.97 %TF, p<0.001) and mean SFA consumption increased by 
3.14 %TF (95% CI: 0.97 %TF to 5.30 %TF, p<0.001) resulting in a decrease 
in the mean P:S ratio of 0.08 (95% CI: -0.15 to 0.00, p= 0.045). In addition, 
there was a significant decrease in mean dietary fibre consumption of 6.77 
g/day (95% CI: -8.58 g/day to -4.96 g/day, p<0.001), in mean percent of 
energy provided by protein of 0.91% (95% CI: -1.74 %E to -0.08 %E, p=0.03) 
and an increase in energy provided by total fat of 1.62% (95% CI: 0.04 %E to 
3.19 %E, p=0.05) during the usual phase. 
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Table 3.3. Mean difference in dietary components consumed in the first and 
final weeks of the chickpea and usual dietary phases1, 2 
  Chickpea phase 
Usual 
phase 
Dietary fibre Mean change 4.30 -6.77 
(g) 95% CI 2.91 to 5.69 -8.58 to -4.96 
 P value <0.001 <0.001 
Total energy Mean change -0.02 -0.23 
(MJ) 95% CI -0.52 to 0.48 -0.54 to 0.08 
 P value 0.93 0.15 
Protein Mean change 0.16 -0.91 
(%E) 95% CI -0.59 to 0.91 -1.74 to -0.08 
 P value 0.67 0.03 
Total carbohydrate Mean change -0.24 -0.12 
(%E) 95% CI -2.08 to 1.60 -1.78 to 1.54 
 P value 0.80 0.89 
Total fat Mean change 0.04 1.62 
(%E) 95% CI -1.74 to 1.82 0.04 to 3.19 
 P value 0.97 0.05 
SFA 3 Mean change -0.97 3.14 
(%TF) 95% CI -2.64 to 0.70 0.97 to 5.30 
 P value 0.25 <0.001 
PUFA 4 Mean change 1.43 -2.66 
(%TF) 95% CI 0.28 to 2.58 -4.35 to -0.97 
 P value 0.02 <0.001 
MUFA 5  Mean change -0.46 -0.47 
(%TF) 95% CI -1.61 to 0.70 -1.66 to 0.71 
 P value 0.44 0.43 
P:S ratio Mean change 0.05 -0.08 
 95% CI 0.00 to 0.09 -0.15 to 0.00 
 P value 0.045 0.045 
1 N=42 
2 P<0.05 denotes a significant difference (repeated measures analysis of variance using 
general linear modelling) 
3 Saturated Fatty Acids 
4 Polyunsaturated Fatty Acids 
5 Monounsaturated Fatty Acids 
 82
 
Table 3.4 shows the difference in mean anthropometric and laboratory 
measurements recorded at the beginning and end of dietary phase. During 
the familiarisation phase, there were small but significant reductions in mean 
body weight of 0.54 kg (95% CI: -0.85 kg to -0.24 kg; p=0.001), in BMI of 
0.19 kg/m² (95% CI: -0.30 kg/m² to -0.09 kg/m²; p=0.001), in serum TC of 
0.18 mmol/L (95% CI: -0.35 mmol/L to -0.01 mmol/L; p=0.04), in fasting 
insulin of 1.11 µIU/ml (95% CI: -1.87 µIU/ml to -0.34 µIU/ml; p=0.01) and in 
HOMA-IR of 0.32 (95% CI: -0.55 to -0.09;.p=0.01). There was a small 
reduction of borderline significance in body weight during the chickpea phase 
of 0.42 kg (95% CI: -0.87 kg to 0.03 kg; p=0.07) and in BMI of 0.16 kg/m2 
(95% CI: -0.23 kg/m2 to 0.01 kg/m2; p=0.07). No other changes in 
anthropometric or laboratory measures were detected, even after adjustment 
for age, gender and BMI. During the usual phase, all values increased, with 
significant increases in mean serum TC of 0.20 mmol/L (95% CI: 0.08 
mmol/L to 0.33 mmol/L, p=0.002), in LDL-cholesterol of 0.19 mmol/L (95% 
CI: 0.05 mmol/L to 0.33 mmol/L, p=0.01), in fasting insulin of 0.75 µIU/ml 
(95% CI: 0.02 µIU/ml to 1.48 µIU/ml; p=0.045) and HOMA-IR of 0.21 (95% 
CI: 0.05 to 0.37; p=0.01). 
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Table 3.4. Mean difference in anthropometric and laboratory measurements 
recorded at the beginning and end of each dietary phase 1, 2 
  Familiarisation phase Chickpea phase Usual phase 
Body weight Mean change -0.54 -0.42 0.03 
(kg) 95% CI -0.85 to -0.24 -0.87 to 0.03 -0.51 to 0.58 
 P value 0.001 0.07 0.90 
Body mass index Mean change -0.19 -0.16 0.01 
(kg/m²) 95% CI -0.30 to -0.09 -0.32 to 0.01 -0.19 to 0.21 
 P value <0.001 0.06 0.94 
Waist hip ratio Mean change 0.00 0.00 0.00 
 95% CI -0.01 to 0.01 -0.01 to 0.01 -0.01 to 0.01 
 P value 0.54 0.84 0.54 
Total cholesterol Mean change -0.18 -0.07 0.20 
(mmol/L) 95% CI -0.35 to -0.01 -0.23 to 0.09 0.08 to 0.33 
 P value 0.04 0.37 0.002 
LDL-Cholesterol Mean change -0.11 -0.05 0.19 
(mmol/L) 95% CI -0.27 to 0.06 0.25 to 0.15 0.05 to 0.33 
 P value 0.20 0.64 0.01 
HDL-Cholesterol Mean change -0.03 -0.01 0.01 
(mmol/L) 95% CI -0.07 to 0.01 -0.06 to 0.03 -0.04 to 0.05 
 P value 0.13 0.53 0.79 
Triacylglycerols Mean change -0.01 -0.09 0.11 
(mmol/L) 95% CI -0.17 to 0.14 -0.30 to 0.13 -0.06 to 0.28 
 P value 0.88 0.44 0.20 
Glucose Mean change -0.10 -0.04 0.18 
(mmol/L) 95% CI -0.29 to 0.10 -0.26 to 0.19 -0.03 to 0.39 
 P value 0.33 0.75 0.09 
Insulin Mean change -1.11 0.39 0.75 
(µIU/ml) 95% CI -1.87 to -0.34 -0.35 to 1.14 0.02 to 1.48 
 P value 0.01 0.30 0.05 
HOMA-IR 3 Mean change -0.32 0.09 0.21 
 95% CI -0.55 to -0.09 -0.09 to 0.27 0.05 to 0.37 
 P value 0.01 0.31 0.01 
Ghrelin Mean change  -54.64  
(ρg/ml) 95% CI  -145.91 to 36.64  
 P value  0.24  
Leptin Mean change  0.61  
(µg/L) 95% CI  -1.26 to 2.47  
 P value  0.52  
1 N=45  
2 P<0.05 denotes a significant difference (repeated measures analysis of variance using general linear 
modelling) 
3 Homeostasis model assessment of insulin resistance, a mathematical model of basal insulin 
sensitivity, derived from fasting glucose and fasting insulin concentrations
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Univariate analysis investigated the effect of change of diet as well as 
selected dietary components on serum TC and insulin concentrations (Table 
3.5). The change in diet (usual compared to chickpea) had the greatest effect 
with a mean increase in serum TC of 0.20 mmol/L and in insulin of 0.89 
µIU/ml. Of the individual dietary components, dietary fibre had greatest effect 
on serum TC, while PUFA and SFA had equivalent but opposing effects on 
serum TC and insulin and protein had a small effect on insulin. With each 
one standard deviation mean increase of dietary fibre consumed, mean 
serum TC decreased by 0.41 mmol/L; with each one standard deviation 
mean increase in PUFA consumed, mean serum TC decreased by 0.30 
mmol/L and insulin by 0.70 µIU/ml. Conversely, with each one standard 
deviation mean increase in SFA, mean serum TC increased by 0.26 mmol/L 
and insulin by 0.75 µIU/ml. When multivariate repeated-measures ANOVA 
was used to adjust for the effect of selected macronutrients that differed 
between the dietary phases the apparent independent effect of the usual diet 
was substantially reduced. Multivariate regression is unable, however, to 
separate the effects of non-independent variables, such as when the quantity 
of chickpeas and the intake of PUFA or dietary fibre or protein are measures 
of the same real thing, or when an increase in PUFA occurs with an 
equivalent decrease in SFA. 
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Table 3.5. Individual effect of Usual versus Chickpea dietary phases and dietary components on serum TC and insulin ¹ 
 Total Cholesterol (mmol/L) Insulin (µIU/ml) 
 Mean difference 2 95% CI P value Mean difference 95% CI P value 
Usual minus Chickpea  0.20 0.06 to 0.33 0.01 0.89 0.14 to 1.64 0.02 
Protein %E (z-score 3) 
(mean 17.96 ± sd 2.85) 0.12 -0.15 to 0.39 0.38 -0.51 -1.05 to 0.04 0.07 
Carbohydrate %E (z-score) 
(mean 46.78 ± sd 6.51) -0.10 -0.39 to 0.19 0.50 1.05 -0.22 to 2.30 0.10 
Total fat %E (z-score) 
(mean 30.44 ± sd 5.69) 0.05 -0.22 to 0.32 0.72 -0.47 -1.56 to 0.62 0.40 
SFA 4 %TF (z-score) 
(mean 42.57 ± sd 7.15) 0.26 0.00 to 0.52 0.046 0.75 0.17 to 1.33 0.01 
PUFA 5 %TF (z-score) 
(mean 17.31 ± sd 5.21) -0.30 -0.53 to -0.08 0.01 -0.70 -1.31 to -0.10 0.02 
MUFA 6 %TF (z-score) 
(mean 41.12 ± sd 4.10) -0.08 -0.33 to 0.17 0.53 -0.42 -0.99 to 0.15 0.15 
Dietary fibre g (z-score) 
(mean 25.89 ± sd 8.02) -0.41 -0.73 to -0.09 0.01 0.33 -1.53 to 2.19 0.73 
 
¹ Repeated measures Analysis of variance using general linear modelling for each variable in the table modelled separately; p<0.05 denotes significant effect 
2 Mean difference for Diet is the mean difference in serum total cholesterol (mmol/L) and fasting insulin (µIU/ml) measured at the end of the chickpea and 
usual dietary phases. For the dietary components, it is the effect of an increase of one standard deviation in the covariant on the mean difference in serum 
total cholesterol (mmol/L)and fasting insulin (µIU/ml) measured at the end of the chickpea and usual dietary phases. 
3 Standardised normal value [= (subject variable value – group mean)/ standard deviation] calculated for each subject 
4 Saturated fatty acids 
5 Polyunsaturated fatty acids 
6 Monounsaturated fatty acids 
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Mean chickpea consumption was significantly increased during the chickpea 
phase by 119 g/day. Adjusting for chickpea content revealed that for every 
one standard deviation increase in mean chickpea content there was a 
corresponding increase in mean energy supplied by protein of 0.57 %E (95% 
CI: 0.01 %E to 1.12 %E; p=0.046) and a significant increase in mean dietary 
fibre consumption of 3.40 g (95% CI: 1.79 g to 5.0 g, p<0.001). Mean PUFA 
and MUFA as a percent of total fat (%TF) also increased with increasing 
chickpea content, whereas mean SFA (%TF) decreased however, none of 
the fatty acid changes were statistically significant. Thus, adding chickpeas to 
the diets significantly increased the energy supplied by protein and dietary 
fibre content while contributing to a decrease in energy supplied by total fat – 
particularly SFA. Further investigation of foods the chickpeas were 
substituting indicated that there was reduced consumption of all food-types 
during the chickpea phase. In particular, mean cereal intake reduced by 44.6 
g/day and vegetables by 37.0 g/day. During the usual phase, consumption of 
dairy foods increased significantly by 50 g/day and highly processed snack 
food consumption increased by 42.6 g/day. 
 
3.4.2 Effect of Chickpea supplementation on satiation and perceived 
bowel function 
Questionnaire analysis (Table 3.6) revealed a significant increase in 
frequency of flatulence during the chickpea phase with a three-fold decrease 
during the usual phase. Perceived general bowel health remained consistent 
throughout the study and there was no change in frequency of defecation. 
Stool consistency did not change significantly during the chickpea phase but 
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participants reported significantly harder stools during the usual phase and 
defecation required more effort. Participants reported significantly higher 
satiation during the chickpea phase. 
 
Table 3.6. Mean difference in bowel function and satiation measured during 
the first and final weeks of the chickpea and usual phases 1, 2 
  
Chickpea 
phase 
Usual 
phase 
Stool  Mean change 0.51 -0.55 
consistency 95% CI -0.11 to 1.12 -1.08 to -0.03 
 P value 0.11 0.04 
Ease of Mean change 1.52 -2.04 
defecation 95% CI 0.81 to 2.23 -2.89 to -1.19 
 P value <0.001 <0.001 
Frequency of Mean change 0.65 -0.77 
defecation 95% CI -0.24 to 1.54 -1.67 to 0.14 
 P value 0.35 0.10 
Frequency of Mean change 0.74 -2.13 
flatulence 95% CI 0.02 to 1.47 -3.26 to -1.01 
 P value 0.04 <0.001 
Perceived general Mean change 0.54 -0.39 
bowel health 95% CI -0.28 to 1.36 -1.43 to 0.65 
 P value 0.20 0.47 
Satiation Mean change 1.49 -1.76 
 95% CI 0.68 to2.30 -2.52 to -1.00 
 P value <0.001 <0.001 
1 N=42 
2 P<0.05 denotes a significant difference (proportional odds modelling by ordinal logistic 
regression for repeated measures ordinal outcome data)  
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3.5 Discussion 
Including four cans of chickpeas per week for 12 weeks, in the ad libitum diet 
of 45 free-living, healthy adults, resulted in small but significant increases in 
mean dietary fibre and PUFA consumption and increased P:S ratio. While 
these changes were not sufficient to affect serum lipid profile, glycaemic 
control, or quantitative measures of satiation or weight loss, small reductions 
of borderline statistical significance in mean body weight and BMI were 
observed. When participants resumed their usual ad libitum diet after 
completing the chickpea phase, small but significant increases were 
observed in mean serum TC, LDL-C, fasting insulin and HOMA-IR. These 
changes coincided with decreased consumption of dietary fibre, protein and 
PUFA and increased consumption of total fat as SFA, resulting in a 
decreased P:S ratio. Small but significant reductions in mean body weight, 
BMI, serum TC, fasting insulin and HOMA-IR during the familiarisation 
phase, suggests that participants were already making healthy dietary 
changes before commencement of the chickpea phase. The changes in 
laboratory and anthropometric measures that occurred during the four-week 
familiarisation phase were consolidated and improved upon during the 
twelve-week chickpea phase, only to return to baseline levels during the four-
week usual phase. This suggests the usual phase was probably closer to the 
participants’ true habitual eating pattern than the familiarisation phase. 
 
It has been suggested that increased dietary SFA impairs both hepatic LDL-
C and glucose clearance and peripheral tissue insulin sensitivity (164, 177) 
while replacement of SFA with PUFA (183) or MUFA (67) reverses this 
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effect. Dietary protein also has an inverse association with insulin sensitivity 
(91, 164). Univariate analysis in the current study, suggested an association 
between serum TC concentration and PUFA, SFA and dietary fibre content 
and an association between insulin concentration and dietary PUFA, SFA 
and protein content. However, as multivariate analysis could not discern the 
effect of PUFA, SFA, protein or dietary fibre independently of the effect of 
chickpeas as a whole, it cannot be determined whether the chickpeas 
themselves caused these changes, the foods they were associated with or 
the foods they replaced. 
 
During the chickpea phase, chickpeas replaced a wide variety of foods from 
all food groups but in particular the cereals, pasta group and the vegetable 
group – both of which include pulses (37). This substitution fitted with the 
observation of greater PUFA and dietary fibre consumption during the 
chickpea phase, as chickpeas contain more fibre and PUFA per 100g than 
wheat (172). Perusal of micronutrient data recorded at the beginning and end 
of the chickpea phase, revealed a small but statistically significant increase in 
mean iron intake and a decrease in mean intake of niacin and potassium. 
Even so, dietary intake for niacin and potassium during the chickpea phase 
was still above the National Health and Medical Research Council 1991 
recommended dietary intakes for Australians (under revision) (123). 
Adjusting for chickpea content suggested chickpeas contributed added 
protein and dietary fibre during the chickpea phase but there was no 
significant association between chickpeas and added PUFA. Thus, the 
increased PUFA consumption may have been due to a combination of added 
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chickpea plus the method of preparation i.e. added PUFA-rich cooking oil or 
dressing. During the usual phase, serves of dairy foods and highly processed 
‘snack’ foods increased significantly, probably explaining the increased 
consumption of total fat and SFA at the expense of PUFA, protein and dietary 
fibre.  
 
Altered dietary fibre intake may also have been associated with qualitative 
changes in satiation during the study (61, 69, 103, 158, 188) and may have 
contributed to small but significant changes in mean body weight and BMI 
observed during the study. Even though perceived satiation increased during 
the chickpea phase, there was no significant decrease in mean ghrelin 
concentrations. Moreover, even though there was a decrease in mean body 
weight there was no significant increase in mean leptin concentration. The 
lack of significant change in leptin and ghrelin concentrations may have been 
partly influenced by consistent intake of total carbohydrate during the study 
(31). Furthermore, the very small reduction in body weight during the 
chickpea phase (0.45 kg over 12 weeks) may have either been 
physiologically not significant - as suggested by a steady WHR, or resulted in 
leptin changes too small to be statistically significant. 
 
It has been suggested that cholesterol lowering by high fibre diets is best 
observed in studies where the dietary fibre intake is very high (25, 72, 138). 
Thus in this study, neither the 4.3g/day increase during the chickpea phase 
nor the 6.8g/day decrease during the usual phase, would have been 
sufficient to cause any significant effect on serum lipid profile due solely to 
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modified dietary fibre intake. Nevertheless, this may have been sufficient to 
affect satiation, faecal bulking and ease of defecation. Three studies 
investigating the effect of small to moderate increases in dietary fibre (3-17g 
of fibre per day) reported increased faecal bulking but no effect on serum 
lipid profile (29). (163) (162). Frequency of flatulence rose marginally during 
the chickpea phase (p=0.046) but fell markedly during the usual phase 
(p<0.001). This suggests participants were experiencing increased frequency 
of flatulence during the familiarisation phase compared to the usual phase 
with increased dietary fibre the most probable cause (36). During a previous 
controlled study by the current authors (Chapter 2), frequency of flatulence 
did not differ between the high-fibre wheat-based diet and a chickpea-
supplemented diet of similar dietary fibre content but was significantly higher 
than during a lower-fibre wheat-based diet. The authors concluded the 
change in amount of dietary fibre was responsible rather than its source. 
 
3.6 Summary and Conclusion 
Including chickpeas in the habitual ad libitum intake of 45 healthy participants 
for 12 weeks resulted in a small but significant increase in mean PUFA and 
dietary fibre intake and a small but statistically significant reduction in mean 
body weight. Participants also reported increased satiation during the 
chickpea phase although this was not borne out by quantitative analysis. 
 
Healthy dietary changes made by participants in the weeks prior to the 
chickpea phase were associated with small but significant decreases in 
serum TC, fasting insulin concentrations and HOMA-IR. During the chickpea 
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phase, these parameters reduced still further but returned to pre-study 
concentrations on resumption of the usual diet. Whether these findings would 
translate to smaller or greater effects in a more hypercholesterolaemic and/or 
hyperglycaemic population is a subject for future study. Results of the current 
ad libitum study support the findings of our previous controlled studies 
(Appendix 1, and Chapter 2), suggesting that chickpeas could be a healthy 
inclusion to the ‘Australian-style’ diet. 
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Chapter 4 
 
General Discussion 
As mentioned in the discussion sections of Chapters 2 and 3 (and Appendix 1), 
it was found that changes in fatty acid consumption, increased dietary fibre 
intake, satiation (degree of fullness leading to meal cessation) and improved 
bowel function were common outcomes of chickpea-supplementation of an 
‘Australian style’ diet. These findings were independent of study location, study 
design or length of dietary intervention. During the collaborative study 
investigating the effect of chickpea consumption on serum lipid profiles 
(Appendix 1), the Melbourne group consumed more carbohydrate and dietary 
fibre and less total fat during the six-week chickpea intervention, perhaps 
‘reflecting changes in food item selection by the participants’ (121). Even so, 
while MUFA and SFA (%TF) consumption was reduced, PUFA consumption 
remained relatively constant. During the controlled study (Chapter 2) 
consumption of PUFA increased and consumption of MUFA decreased during 
the five-week controlled chickpea phase but SFA (and total fat) consumption 
remained constant. Increased frequency of flatulence was associated with fibre 
content rather than fibre source, bowel health was not adversely affected during 
the chickpea intervention and satiation was high. The 12-week chickpea phase 
of the ad libitum study (Chapter 3) revealed increased consumption of PUFA 
and dietary fibre, which decreased during the usual phase. Bowel function was 
again significantly improved and reported satiation was higher during the 
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chickpea phase compared to the usual diet. Statistical analysis suggested that 
the small but significant increases in mean PUFA consumption was the dietary 
component most consistently associated with small but significant reductions in 
mean serum LDL-C and TC, (with little effect on HDL-C or triacylglycerols) 
observed after the chickpea phases compared to the controlled wheat and usual 
ad libitum phases. However, multivariate analysis could not separate the effect 
of PUFA from the overall effect of PUFA -rich chickpeas. During the usual phase 
of the ad libitum study, small but significant increases in fasting insulin 
concentrations and HOMA-IR were most strongly associated with increased 
mean SFA and concomitant decreased PUFA intake. Again, multivariate 
analysis could not distinguish between the overall effect of chickpeas and PUFA 
(or SFA) concentration on changes in glycaemic control. During the controlled 
study, no such changes in insulin or HOMA-IR were detected, probably because 
the fatty acid substitution was PUFA for MUFA while SFA intake remained 
constant. 
 
A meta-analysis of 224 dietary intervention studies conducted between 1966 
and 1994 (64), reported that change in SFA and PUFA intake, and thus the P:S 
ratio, were still the most robust predictors of change in LDL-C, regardless of 
‘interactions of dietary factors, initial dietary intakes and serum concentrations, 
study and subject characteristics’. Multivariate analysis of a meta-analysis of 
395 metabolic ward studies involving 129 groups of participants conducted 
between 1962 and 1995 (27), reported that isocaloric increases in PUFA (5 %E) 
at the expense of carbohydrate, were associated with significantly reduced 
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blood TC and LDL-C while MUFA showed no significant effect and SFA 
significantly increased both LDL-C and HDL-C. The effect of SFA was about 
twice as strong as that of PUFA. These associations persisted regardless of 
gender, age, BMI or habitual energy intake. It needs to be noted however, that 
the type of carbohydrate used could influence its effects on serum lipid profile (7, 
67, 69, 103, 125, 128). In the same meta-analysis, isocaloric replacement of 
SFA (10 %E) with unsaturated fats (5 %E MUFA plus 5 %E PUFA) was reported 
to be three times more effective at reducing blood TC than isocaloric 
replacement of total fat with complex carbohydrate and did not affect HDL-C 
concentrations. It was emphasised that while isocaloric substitution of SFA by 
PUFA (< 10 %E) or MUFA may improve lipid profiles, it would not help control 
obesity but evidence from more recent studies indicates otherwise. Recent 
reviews suggest that dietary PUFA in particular may exert a direct effect on 
lipogenesis in the liver especially,  by promoting fatty acid β-oxidation and 
suppressing lipid synthesis via regulation of peroxisome proliferator-activated 
receptors (PPARα & PPARγ) (3, 141). 
 
An increase in reported satiation during the higher fibre interventions of the 
controlled dietary studies had suggested that in ad libitum environments 
chickpea consumption might contribute to reduced dietary intake and perhaps 
weight loss. This did happen, but only to a very small extent. During the 
chickpea phase of the ad libitum study, participants very successfully 
incorporated chickpeas into their habitual dietary pattern with very little change 
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in energy intake. Even so, there was a small but significant increase in mean 
dietary fibre intake and a small but significant decrease in mean body weight, 
compared to the usual phase. The change in body weight may have been too 
small to elicit a significant change in leptin concentration, or may not have been 
physiologically significant. It is noted that there was a lack of change in WHR. 
The absence of significant change in ghrelin concentrations during the chickpea 
phase may have been influenced by the consistent intake of total carbohydrate 
during the study (31) and supported the earlier finding that reported high 
satiation was due to increased dietary fibre intake (Chapter 2). 
 
The subsequent dietary adjustments observed during the chickpea phase 
revealed an overall substitution of all food-types with chickpeas, although the 
food groups most affected were those in which pulses are included. 
Micronutrient intake did not seem to be adversely affected by chickpea 
substitution, although more detailed investigations involving biomarkers of 
micronutrient absorption would need to be performed to substantiate this and 
monitor any possible effects on blood levels. Less consumption of dairy and high 
fat snack foods occurred during the chickpea phase compared to the usual 
phase. This is consistent with participants’ comments of eating fewer between 
meal snacks during the chickpea phases of the controlled and ad libitum studies. 
 
Another consistent finding during these studies was the relative ease with which 
participants adjusted to the chickpea interventions - whether they were of five- or 
12-weeks duration. The degree of support and encouragement provided by the 
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investigators along with an extensive range of recipes and preparation ideas, to 
help participants incorporate the chickpeas into their diets, would have 
contributed. The majority of participants reported no ill effects from chickpea 
consumption, apart from increased flatulence, although a number reported 
feeling very full and bloated during the initial weeks of the ad libitum chickpea 
phase. Once participants had adjusted their dietary intake to accommodate the 
chickpeas, acceptance was very high. Of the 102 participants who commenced 
the studies, only three of the ten withdrawals cited chickpea-associated issues 
as the reason for their withdrawal. 
 
There has been little research into chickpeas and human health compared to 
that involving other pulses. Previous research has determined the glycaemic 
index of chickpeas (73, 101); investigated the effect of chickpea consumption on 
serum lipid profile compared to other hypocholesterolaemic agents (49) and 
after ingestion of a high SFA diet (106) and investigated the effect of chickpea 
consumption on glycaemic control (121). The intention of the current studies 
was not only to add to this small body of research but also to create practical, 
real-life scenarios that would be easily attainable for individuals interested in 
reducing their diet-related CVD risk factors. Participants with greater likelihood 
of having CVD risk factors (40 years or older, overweight, mildly 
hypercholesterolaemic/ hyperglycaemic) but otherwise healthy were invited to 
participate. In addition, it was hoped that changes to metabolic parameters 
would be more likely to be detected if the parameters to be measured were 
initially, mildly elevated. However in practice, a number of the participants did 
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not have baseline abnormalities. The five-week, controlled, dietary interventions 
were of sufficient length to allow for stabilisation of metabolic parameters without 
affecting participant compliance. The 12-week, ad libitum, chickpea phase 
facilitated detection of potential incremental change in anthropometric measures 
and allowed observation of dietary substitution due to chickpea 
supplementation. Consideration of participant compliance also influenced the 
quantity of chickpeas to be used. Larger quantities of chickpeas may have 
resulted in greater changes in measured parameters but may have been difficult 
for participants to consume for the duration of the intervention phases and 
impractical for longer term consumption. As it was, participants reported initial 
difficulty in consuming the allocated quantity of chickpeas during both the five- 
and 12-week phases and took a little time to adjust - especially during the ad 
libitum diet where dietary adjustment was the responsibility of the participants 
rather than controlled by the investigators. After 12 weeks (3 months), using the 
modest quantity we chose, participants were happily adjusted to their changed 
diet and some were reluctant to return to their former dietary habit. 
 
Overall, reported bowel function either did not change, or improved following 
chickpea consumption, in particular, ease of defecation and faecal bulking. This 
small effect may have been because the increase in dietary fibre during the 
chickpea interventions was relatively small. Again, consumption of larger 
amounts of chickpeas may have produced larger increases in dietary fibre with 
greater change in bowel function; however participants may have found such 
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intervention diets less tolerable with potentially a greater incidence of 
undesirable side effects. 
 
In summary, addition of chickpeas to an ‘Australian-style’ diet under easily 
attainable controlled and ad libitum conditions resulted in small but healthy 
changes to serum lipid profile, bowel function and satiation. Relatively new 
biomarkers of satiation and energy balance, ghrelin and leptin, remained 
unchanged during the ad libitum chickpea phase, even though small borderline 
significant reductions in body weight were observed. This may have been due to 
consistent carbohydrate intake throughout the study. Participant compliance was 
high but they received a lot of support and information. Informing and educating 
the general population about incorporation of chickpeas into their diets would be 
a challenge but may facilitate greater awareness and acceptance of chickpeas 
and other pulses as healthy additions to the Australian diet. 
 
Future directions for investigation of the long-term effect of chickpeas on CVD 
risk factors may sensibly focus on the effect of chickpea intervention in more 
obese, hyperglycaemic, hypercholesterolaemic populations and in studies 
designed to incorporating a weight-reducing dietary phase. The challenge would 
be to fashion diets that had minimal effect on leptin concentrations while 
suppressing ghrelin concentrations, thus increasing satiation and minimising 
appetite stimulation while maximising weight loss. The consistent reports of 
increased satiation also suggest further research is warranted into the effects of 
chickpeas on post-prandial glycaemic response and between-meal satiety. 
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Appendix 1 
 
Dietary supplementation with chickpeas for at 
least five weeks results in small but significant 
reductions in serum total- and LDL-cholesterol 
in adult women and men. 
 
J.K. Pittaway, K.D.K. Ahuja, I.K. Robertson, P.J. Nestel, M.J. Ball 
 
Abstract 
Objective: To compare the effect of a chickpea-supplemented diet with a 
wheat-supplemented diet on human serum lipids and lipoproteins. 
Method: Forty-seven free-living adults participated in a randomised crossover 
weight maintenance dietary intervention involving two dietary periods (chickpea-
supplemented and wheat-supplemented) each of at least five weeks duration 
each.  
Results: Serum total cholesterol (TC) and low-density-lipoprotein cholesterol 
(LDL-C) were significantly lower (both p<0.01) by 3.9% and 4.6% respectively, 
after the chickpea-supplemented diet compared to the wheat-supplemented diet. 
Protein (0.9% of energy, p=0.01) and monounsaturated fat (3.3% of total fat, 
p<0.001) intake was slightly but significantly lower and carbohydrate intake was 
significantly higher (1.7% of energy, p<0.001) on the chickpea-supplemented 
diet compared to the wheat-supplemented diet. Multivariate analyses suggested 
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that the differences in serum lipids were mainly due to small differences in 
polyunsaturated fatty acid and dietary fibre between the two intervention diets. 
Conclusions: Inclusion of chickpeas in an intervention diet results in a lower 
serum TC and LDL-C compared to a wheat-supplemented diet.  
 
Introduction 
Research has indicated a strong association between dietary patterns and 
cardiovascular disease (CVD) (70). A high intake of saturated fats and a low 
intake of dietary fibre have been strongly associated with high blood lipids (7, 70, 
90, 111), a prominent risk factor for CVD (2, 189). Legumes and pulses are low 
in saturated fat and higher in polyunsaturated fat, protein and complex 
carbohydrates. They are a good source of resistant starch, soluble and insoluble 
dietary fibre (48, 129, 134, 172). Examination of the literature reveals a gradual 
development of interest in the contribution of legumes and pulses to a healthy 
lifestyle (17, 40 ). In human studies, consumption of pulses has been associated 
with reduction of hypercholesterolaemia (5, 8, 119) and reduced risk of coronary 
heart disease (CHD) (17). 
 
Chickpeas have been a staple part of Indian, Mediterranean and African diets 
for many thousands of years (48, 160). Worldwide, they are the second most 
cultivated pulse worldwide and the third largest in terms of the amount of pulse 
produced worldwide (129, 157, 191). They are, however, a relatively novel 
addition to Western cuisine. Every 100g of dried chickpeas contain 19.3g of 
protein, which compares favourably with wheat at 10.7g (172). In contrast to 
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most other pulses and cereals, chickpeas have a relatively high fat content. This 
makes them an important energy source for vegans and those without regular 
access to meat and dairy products - the fat is mostly polyunsaturated, with less 
than 1% saturated fat (172). While the ratio of soluble to insoluble fibre in 
legumes is comparable to grains (approximately 1:3 for both) (175) per 100g 
edible portion, chickpeas contain 17.4g total dietary fibre compared to 12.7g for 
wheat (172). Chickpeas are a rich source of vitamins, minerals and 
phytoestrogens. They are relatively free of antinutrients, such as lectins, but do 
contain small amounts of saponins, some tannins and phytate (51, 129, 134). 
 
There are only two studies which have examined the potential benefits of 
chickpeas on human health, especially with regard to hypercholesterolaemia (49, 
106). Additional research is required to gain a better understanding of the effects 
of chickpeas in the human diet, especially on CVD risk factors. Thus, the aim of 
this research was to compare the effects of a chickpea-supplemented diet with 
the effects of a wheat-supplemented diet on serum lipids and lipoproteins. The 
latter diet was chosen as a comparison because the ‘usual Australian’ diet is 
based on food products made from wheat, e.g. bread, breakfast cereals and 
pasta. This manuscript presents results obtained from two very similar studies 
undertaken in Launceston (Tasmania) and Melbourne (Victoria).  
 
Participants and Methods 
Participants and Study Design 
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Free-living adults aged 30 to 70 years, not taking cholesterol-lowering 
medication were invited to participate. Each participant provided signed, 
informed consent. The Northern Tasmania Health and Medical Human 
Research Ethics Committee (Launceston, Tasmania) and the Alfred Research 
and Ethics Unit (Melbourne Victoria) granted approval for the studies. The 
studies followed a randomized crossover design, with two periods of dietary 
intervention - a chickpea-supplemented (chickpea) diet and a wheat-
supplemented (wheat) diet. The Launceston group had dietary intervention 
periods of five weeks duration, separated by an eight-week period over the 
Christmas recess, when food intake and lifestyle is usually different. The 
Melbourne group had intervention periods of six weeks duration without an 
intervening period (121), as they commenced in June and completed the study 
before Christmas. The comparison was of dietary intakes and blood lipid 
concentrations at the end of the chickpea-supplemented and wheat-
supplemented diets. It did not monitor the changes from a ‘baseline’ value 
influenced by uncontrolled usual diet. It has been reported that it takes four 
weeks for blood lipid levels to reflect the effects of altered dietary intake where 
iso-energetic conditions prevail (145, 146), and the intervention periods were a 
minimum of five weeks to allow stabilisation.  
 
Dietary Design 
Before starting the dietary intervention periods, participants were asked to 
record their complete food consumption over four days (two week days and two 
weekend days)  in their weighed food diet diaries, which were used to calculate 
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usual dietary energy intake using Food Works version 2.10 with the Nuttab 95 
and AusNut database (Xyris software, Brisbane, Australia). The intervention 
diets (chickpea and wheat) were then devised to be iso-energetic with and 
based on the participants’ habitual diet. An attempt was also made to match the 
total fat, carbohydrate, protein and dietary fibre intake between the two 
intervention periods. 
 
The chickpea diet involved daily consumption of 140 g (2 serves) of canned, 
drained chickpeas, chickpea bread and chickpea shortbread biscuits. The 
chickpeas (Edgell, Australia, 300g net weight) from the same date/batch of 
canning were provided to the participants. Bread and the shortbread biscuits 
containing 30% chickpea flour were provided by the Grain Research 
Development Corporation (Canberra, Australia). This ensured the intake of the 
same type and variety of chickpeas and chickpea products between participants 
in the two research centres. Chickpea and chickpea based foods (bread and 
biscuit) contributed approximately 3.4 MJ of energy per day with 16% of energy 
from protein, 19% of energy from total fats, and 65% of energy from 
carbohydrates and approximately 27g of dietary fibre. The wheat diet involved 
consumption of wholemeal (wheat) bread, high fibre (wheat) breakfast cereals 
(>2.5g fibre/100g) and shortbread biscuits that participants purchased from their 
usual grocery suppliers.  
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Participants were provided with a list of the amount and variety of foods allowed 
during the two dietary periods. Fruit and vegetable and fat intake was kept 
similar between the two intervention periods. Participants were requested to 
refrain from eating any foods with cholesterol-lowering claims, (e.g. phytosterol 
margarine), legumes (other than the chickpeas supplied) or foods with high fibre 
claims (e.g. 'fibre enriched' yogurt or fruit juices). Participants were advised not 
to take more than two standard drinks of alcohol per day. Participants were also 
asked to maintain their usual pattern of physical activity and body weight 
throughout the study period. 
 
Participants were contacted regularly to discuss any problems related to diets 
and to provide encouragement and support. Participants again recorded their 
four days of dietary intake in the last week of the two intervention diets. These 
were analysed using FoodWorks software (Xyris, Brisbane, Australia) to 
calculate and compare nutrient intake between the two intervention diets and to 
check the dietary compliance.  
 
Laboratory measurements and Statistics 
Venous blood samples at the start and the end (day 36 for Launceston Group 
and day 43 for the Melbourne group) of the two dietary periods were collected at 
rest, after an overnight fast of ten hours. For serum separation, the blood was 
allowed to coagulate for one hour and then centrifuged at 800g at 4°C for 20 
minutes. Serum was aliquotted and stored at -70°C, for later analysis. All 
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biochemical analyses were subsequently performed in the same run, to reduce 
inter-assay variability. 
 
Lipid measurements were performed in complete runs for each participant using 
an autoanalyser. In Launceston this was an RA 1000 auto analyser (Technicon, 
USA) and Thermotrace reagents (Thermo Electron Corporation, USA), whilst in 
Melbourne a Roche Hitachi 917 autoanalyser and Roche reagents (Roche 
Diagnostics, Australia) was used. LDL-C for both groups was determined using 
Friedwald's equation (45) 
 
Repeated measures ANOVA (STATA version 8.2, StataCorp, College Station, 
Texas USA) performed by general linear modelling (GLM) was used to compare 
the ingestion of nutrients during the chickpea and the wheat-supplemented diets 
and to determine the effect of diet on the serum lipids and lipoproteins. 
Univariate and multivariate analyses were used to assess the associations 
between the dietary intakes and lipid profiles. All data were adjusted for the 
order of diet (chickpea then wheat or wheat then chickpea) and the 
chronological order of blood sample collection (order and period effects). The 
results were expressed as the effect size. For categorical variables such as the 
diet (chickpea or wheat), the effect size was the difference in cholesterol levels 
(mmol/l) between the two group variables. For continuous dietary component 
variables (such as fibre, PUFA as % of dietary fat), the standard normal value or 
z-score [= (subject variable value – group mean)/ standard deviation]) was 
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calculated for each dietary variable for each subject. The effect size for 
continuous variables was the change in cholesterol levels (mmol/l) associated 
with a rise of one standard deviation in the dietary variable. Data from each 
study centre were analysed separately and as a combined group.  
 
Results 
Fifty-two people commenced the study (Launceston 31; Melbourne 21). Three 
participants withdrew due to employment commitments and two more due to 
abdominal discomfort attributed to ingestion of chickpeas. Thus, 47 participants 
(Launceston 27; Melbourne 20) completed the study: 28 females and 19 males. 
The mean (±SD) age, weight and BMI at the start of the intervention study was 
53.0 ± 9.8; 79.3 ± 16.3 kg and 27.6 ± 4.1 kg/m² respectively.  
 
There was no significant difference in the body weight and BMI between the 
start and the end of each dietary period, or the ends of the two intervention diets 
(all p>0.2). The body weight and BMI at the end of the chickpea diet were 
79.1±16.1 kg and 27.1 ± 4.1 kg/m² while that at the end of the wheat diet were 
79.0 ±16.4 kg and 27.1 ± 4.1 kg/m², respectively. Similarly, serum lipids and 
lipoproteins were not significantly different at the start of the two intervention 
diets (p>0.6 for serum TC, LDL-C, HDL-C, and triacylglycerol).  
 
Table 1 shows the mean daily energy, macronutrient, and dietary fibre intake of 
participants from the final week of each dietary phase. Dietary records, 
participant feedback and a differential count of cans of chickpeas provided, 
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indicated that participants consumed the requisite amount of chickpea and 
wheat products.  
 
Launceston group: There was a small but significantly lower intake of protein 
(1% of energy; p=0.04) during the chickpea diet compared to the wheat diet. 
Furthermore, there was a significantly higher intake of polyunsaturated fatty 
acids (PUFA) (2.9 % of total fat; p=0.01) and a lower intake of monounsaturated 
fatty acids (MUFA) (3% of total fat; p=0.03) during the chickpea diet compared 
to the wheat. 
 
Melbourne group: A small but statistically significant lower consumption of total 
fat (2.2% of energy; p=0.02), saturated fatty acids (SFA) (2.9% of total fat; 
p=0.03) and MUFA (3.7% of total fat; p=0.002) was observed during the 
chickpea diet compared to the wheat diet. In contrast, there was a significantly 
higher intake of dietary fibre (7.0 g; p=0.02) and carbohydrate (2.7% of energy; 
p=0.01) intake during the chickpea diet compared to the wheat. 
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Table 1 Daily macronutrient intake of the participants during the chickpea- and wheat-based diets and end-diet body-
weights.¹ 
 
 Launceston (n=24) Melbourne (n=19) Combined (n=43) 
 Chickpea Wheat Chickpea Wheat Chickpea Wheat 
Body-weight kg 83.9 ± 17.3 83.8 ± 17.3 72.7 ± 12.1 72.5 ± 12.6 79.1 ± 16.1 79.0 ± 16.4 
Dietary fibre g 28.4 ± 5.1 29.3 ± 7.4 33.1 ± 8.2 a 26.1 ± 13.3 30.5 ± 7.0 27.9 ± 10.4 
Total energy intake mJ 8.9 ± 1.3 9.1 ± 1.5 7.4 ± 2.9 7.5 ± 4.0 8.2 ± 2.3 8.4 ± 2.9 
Protein %E 17.2 ± 2.7 a 18.2 ± 3.2 19.3 ± 2.2 20.0 ± 2.2 18.1 ± 2.7 a 19.0 ± 2.9 
Carbohydrate %E 43.6 ± 5.5 42.6 ± 5.1 48.7 ± 6.4 a 46.0 ± 6.9 45.8 ± 6.3 a 44.1 ± 6.1 
Total fat %E 33.9 ± 5.2 34.0 ± 4.9 29.7 ± 7.6 a 31.9 ± 7.8 32.0 ± 6.6 33.1 ± 6.4 
saturated fatty acids %TF 40.5 ± 8.2 40.4 ± 7.2 34.7 ± 6.2 a 37.7 ± 6.0 38.0 ± 7.8 39.2 ± 6.7 
polyunsaturated fatty acids %TF 17.6 ± 4.6 a 14.7 ± 3.2 16.6 ± 5.9 17.4 ± 5.7 17.1 ± 5.2 15.8 ± 4.7 
monounsaturated fatty acids %TF 42.0 ± 7.8 a 45.0 ± 6.0 31.3 ± 5.0 a 35.0 ± 3.5 37.3 ± 8.5 a 40.6 ± 7.1 
 
¹ Values are means ± one standard deviation 
² Expressed as the percentage of total energy (%E) or total fat (%TF) consumed per day 
a Means differ between chickpea- and wheat-based diets (Repeated measures Analysis of variance, p<0.05) 
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There was no significant difference in total energy intake of the individual or 
combined group. The combined group showed a small but statistically significant 
lower protein intake (0.9% of energy; p=0.01) and MUFA intake (3.3% of total fat; 
p<0.001) on the chickpea diet compared to the wheat diet. Conversely, 
carbohydrate intake was slightly but significantly higher (1.7% of energy; p=0.02) 
on the chickpea diet compared to the wheat diet. Alcohol intake was similar 
between the two intervention diets (p=0.49). 
 
 
There was no heterogeneity in the effect of diet between the two centres (centre 
difference TC 0.08, 95% C.I. -0.16 to 0.32, p=0.51; LDL-C 0.03, 95% C.I. -0.18 
to 0.25, p=0.77). Thus analysis to determine the effect of selected dietary 
components on serum TC and LDL-C was performed on the combined group.  
 
Serum TC was 3.9% lower (0.22 mmol/l; 95% C.I. 0.1 to 0.35; p=0.001) and 
LDL-C was 4.6% lower (0.18 mmol/l; 95% C.I. 0.07 to 0.29; p=0.002) at the 
completion of the chickpea diet compared to the wheat diet for the combined 
group (Table 2). The Launceston group showed a 4.1% lower (p=0.01) TC and 
3.0% lower (p=0.03) LDL-C after the chickpea diet compared to the wheat diet. 
For the Melbourne group TC was 3.5% (p=0.05) and LDL-C was 4.4% (p=0.04) 
lower after the chickpea-supplemented diet compared to the wheat-
supplemented diet. Serum HDL-C and triacylglycerol levels were not 
significantly different between the two intervention diets (either in the separate or 
the combined groups).
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Table 2 Serum lipid profiles of participants at the end of each dietary period¹ 
 Launceston (n=27) Melbourne (n=20) Combined (n=47) 
 Chickpea Wheat Chickpea Wheat Chickpea Wheat 
TC²  mmol/L 5.88 (5.36 to 6.39)a 6.13 (5.62 to 6.65) 5.58 (5.14 to 6.02)a 5.78 (5.35 to 6.17) 5.75 (5.40 to 6.11)a 5.98 (5.62 to 6.33) 
LDL-C³ mmol/L 3.89 (3.45 to 4.33)a 4.01 (3.65 to 4.52) 3.46 (3.13 to 3.78)a 3.62 (3.26 to 3.40) 3.71 (3.41 to 4.01)a 3.89 (3.58 to 4.20) 
HDL-C4 mmol/L 1.33 (1.19 to 1.47) 1.36 (1.21 to 1.50) 1.46 (1.26 to 1.67) 1.49 (1.29 to 1.68) 1.39 (1.27 to 1.51) 1.41 (1.29 to 1.53) 
Tri5 mmol/L 1.44 (1.14 to 1.75) 1.53 (1.31 to 1.75) 1.47 (0.85 to 2.09) 1.46 (1.03 to 1.89) 1.46 (1.15 to 1.76) 1.50 (1.28 to 1.72) 
 
¹ Values are means with (95% confidence intervals) adjusted for order of diet and chronological order of measurement 
² Serum total cholesterol 
³ Low density lipoprotein cholesterol 
4 High density lipoprotein cholesterol 
5 Triacylglycerols 
a Means differ between chickpea- and wheat-based diets (Repeated measures Analysis of variance, p<0.05) 
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Analysis revealed a substantial effect of the chickpea diet as a whole on the 
serum TC (p=0.001) and LDL-C (p=0.002) compared to the wheat diet. The 
apparent association between individual nutrients and lipids was assessed by 
univariate regression. Dietary fibre showed the strongest association, with a 
reduction in serum TC of 0.24 mmol/l (95% C.I. -0.47 to -0.02 mmol/l; p=0.03) 
and in serum LDL-C of 0.21 mmol/l (95% C.I. -0.42 to -0.01 mmol/l; p=0.04) for 
each increase in standard deviation in fibre intake. Multivariate analyses showed 
that about 55% of the difference in serum TC and 78% in LDL-C could be 
attributable to the combined effect of fibre and PUFA in the chickpea diet (Table 
3), as these were the reductions in measured diet effect size when adjusted for 
these confounding variables. 
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Table 3 The combined effects of chickpea-supplemented versus wheat-supplemented diets and selected dietary 
components on total and LDL cholesterol¹ 
  Total Cholesterol  LDL 
  Effect size 2 95% CI P value  Effect size 2 95% CI 2 P value 
Diet:           Chickpea versus wheat  -0.10 (-0.31 to 0.11) 0.34  -0.04 (-.24 to 0.16) 0.72 
Total fat:        (Mean 32.6 ± sd 6.5) % E 4 0.00 (-0.19 to 0.19) 0.99  0.15 (-0.04 to 0.33) 0.12 
PUFA:            (Mean 16.5 ± sd 4.9) % TF 5 -0.12 (-0.35 to 0.11) 0.33  -0.19 (-0.33 to 0.07) 0.21 
MUFA:           (Mean 38.9 ± sd 8.0) % TF 5 0.06 (-0.14 to 0.25) 0.56  -0.09 -0.25 to 0.07 0.26 
Dietary fibre:  (Mean 29.2 ± sd 8.9) g -0.24 (-0.48 to -0.0) 0.05  -0.24 -0.47 to 0.00 0.05 
 
¹ Multivariate repeated measures ANOVA using general linear modelling. Each model includes the variables with recorded coefficients, adjusted 
for order of diet and chronological order of measurement, n=47 
² Values expressed as mmol/L 
3 Effect size for Diet is the difference in serum TC and LDL (mmol/L) between the two intervention diets. For the dietary components it is the effect 
of an increase of 1 std. dev. in the covariant on the serum total cholesterol and LDL (mmol/L) 
4 Value expressed as percentage of daily energy intake 
5 Value expressed as percentage of daily total fat intake 
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Discussion 
This study investigated and compared a chickpea-supplemented and a wheat-
supplemented diet (of at least five weeks of dietary intervention) in 47 men and 
women attending two separate centres, and showed a significantly lower 
concentration of serum TC and LDL-C after the chickpea-supplemented diet.  
 
Although a small but significant difference was observed in the protein, 
carbohydrate and MUFA intake between the two intervention diets, statistical 
analyses indicated that this was not a significant effect. Most of the differences 
in the lipids and lipoproteins could be attributed the chickpea diet as a whole, 
and the small differences in the dietary fibre and PUFA on the chickpea diet 
compared to the wheat diet. Interpretation of this should be cautious, since 
dietary fibre and PUFA are characteristic components of the chickpeas, and 
regression analysis may be unreliable when separate measures of the same 
property (in this case dietary fibre and the PUFA on the one hand, and chickpea 
diet on the other) are included in the same regression model. Certainty about 
whether it is the fibre and PUFA components of chickpea having the effect as 
opposed to some other property of the chickpeas would require an experimental 
rather than a statistical approach.  
 
A wealth of data is available from other dietary intervention trials showing much 
larger reductions in serum total and LDL cholesterol with increased intake of 
fibre or PUFA. However, most studies have included substantially higher 
amounts of fibre or PUFA to show those changes. Cholesterol-lowering by high 
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fibre diets is best observed in studies where the dietary fibre intake is very high 
(25), as much as two to three times the recommended intake (138). Similarly, 
although high PUFA diets have shown the changes in serum lipids, concerns 
have been raised about the effects of high intake of PUFA (>8% of total energy) 
reducing the HDL-C concentrations (44). In contrast, we present here a 
palatable food (chickpea) containing slightly higher amounts of dietary fibre and 
PUFA compared to wheat, that can be easily substituted for small amounts of 
wheat in weight maintenance ‘Western’ diet to show a small but significant 
change in serum TC and LDL-C without affecting the HDL-C.  
 
Earlier studies that investigated the hypocholesterolemic effects of chickpeas 
(variety used was Bengal Gram) reported greater reductions in serum 
cholesterol concentrations than were observed in the present investigation (49, 
106). This may have been due to the differences in the population studied, the 
study design and/or the type of chickpeas used. While the earlier studies were in 
Indians, the present study group was mainly Caucasian. The chickpeas more 
commonly consumed in India and Pakistan  (desi/Bengal gram) contains about 
three times more fibre than the Kabuli chickpeas used in our study  (79). In 
addition, the previous research protocols first induced hypercholesterolemia 
(with high fat diets of 10 weeks) before adding chickpeas to the diet (106).  
 
Thus, chickpeas may have a role in reducing CHD risk. Although the differences 
in serum total and LDL-C were small (approximately 4%) previous research 
suggests that a 5% reduction (~0.3mmol/L) in total cholesterol through dietary 
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intervention may reduce the risk of ischemic heart disease by about 15% at the 
age of 60 years (179). The results from the present investigation would equate 
to a 13.5% reduced risk. They were achieved with a practical dietary fibre intake 
around the recommended dietary intake of 30g/day (37). Further research is 
required to evaluate whether the differences observed in the present controlled 
situation prevail or are accentuated when chickpeas are added to the long term 
ad libitum diet. 
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The effect of chickpeas on human serum lipids and lipoproteins 
JK Pittaway¹, KDK Ahuja¹, A Chronopoulos², M. Cehun², IK Robertson¹, PJ Nestel², 
MJ Ball¹,  
¹School of Human Life Sciences, University of Tasmania, Launceston TAS 7250 
²Baker Heart Research Institute, Melbourne VIC 8008  
 
Background- Consumption of pulses has been associated with reduction of 
hypercholesterolaemia and reduced risk of coronary heart disease (CHD). Chickpeas have 
been a staple part of Indian, Mediterranean and African diets for many thousands of years 
but are a relatively novel addition to Western cuisine. 
Objective- To compare the effect of a chickpea-supplemented diet with a wheat-based diet   
on human serum lipids and lipoproteins. 
Design- Randomized, crossover dietary interventions each at least five weeks in duration, 
involving 47 free-living adults with at least one CHD risk factor, or a family history of CHD. 
Intervention diets were isoenergetic to the participants’ usual diet, designed to be matched 
for macronutrient content and controlled for dietary fibre. Chickpeas were consumed in the 
form of canned, drained chickpeas and in bread and biscuits containing 30% chickpea flour. 
Results were analysed using repeated measures ANOVA by general linear modelling. 
Outcomes- Reductions in the concentration of serum total cholesterol (3.9%) and low 
density lipoprotein-cholesterol (4.7%) on completion of the chickpea diet compared to the 
wheat diet. When corrected for the effect of gender, age, total fat, percent fatty acid 
composition and dietary fibre, the effect of diet on total cholesterol and low density 
lipoprotein cholesterol disappeared. 
Conclusions- Despite attempts at controlling macronutrient intake, the inclusion of 
chickpeas in the intervention diet caused changes in dietary fat and fibre composition, 
leading to reduced serum total and low density lipoprotein cholesterol. 
Sponsorship- Grain Research Development Corporation, Australia 
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Background: Consumption of pulses has been associated 
with reduction of hypercholesterolaemia and reduced risk of 
coronary heart disease (CHD). Chickpeas have been a staple 
part of Indian, Mediterranean and African diets for many 
thousands of years but are a relatively novel addition to 
Western cuisine.
Objective: To compare the effect of a chickpea-
supplemented diet with a wheat-based diet on human serum 
lipids and lipoproteins.
Design: Randomised, crossover dietary interventions each at 
least five weeks in duration, involving 47 free-living adults (28 
women, 19 men) with at least one heart disease risk factor (age 
>40 years, obesity, hypertension, sedentary lifestyle, elevated 
blood cholesterol) or a family history of CHD. Intervention 
diets were isoenergetic to the participants’ usual diet, designed 
to be matched for macronutrient content and controlled for 
dietary fibre. Chickpeas were consumed in the form of canned 
drained chickpeas and in bread and biscuits containing 30% 
chickpea flour. A wheat-based diet was used as the comparison 
because the ‘Australian’ diet is mostly wheat-based. Results 
were analysed using repeated measures ANOVA by general 
linear modelling.
Results: The mean (SD) age of the study group was 53.9 
(9.8) years and BMI 27.6 (4.1). There was no change in body 
weight after the two dietary periods. The two diets were not 
significantly different in energy content but differed in dietary 
fatty acid composition, carbohydrate and dietary fibre (see 
Table 1).
A significantly lower concentration of serum total 
cholesterol (3.9%) and low density lipoprotein cholesterol 
(4.7%) was found on completion of the chickpea diet 
compared to the wheat diet. No difference was detected in 
serum high density lipoprotein cholesterol or triglycerides. 
When corrected for the effect of gender, age, total fat, 
percent fatty acid composition and dietary fibre, the effect 
of the chickpea diet on serum total cholesterol was reduced 
from a difference of 0.22 mmol/L (95% C.I. 0.10 to 0.35 
mmol/L, p=0.001) to a difference of 0.10 mmol/L (95% 
C.I. -0.31 to 0.11 mmol/L, p=0.34). The corrected effect of 
the chickpea diet on low density lipoprotein-cholesterol 
was reduced from a difference of 0.18 mmol/L (95% C.I. 
0.07 to 0.29 mmol/L, p=0.002) to a difference of 0.04 
mmol/L (95% C.I. -0.24 to 0.16 mmol/L, p=0.72).
Conclusion: Including chickpeas in an Australian diet 
improved the lipid profile consistent with reduced risk of 
CHD. It was not possible to determine whether this was due 
to the changes in dietary fat and fibre, or the specific 
presence of chickpeas – although this distinction may be of 
little practical importance. Further investigation is 
warranted.
JK Pittaway¹, KDK Ahuja¹, M Cehun², A Chronopoulos², IK Robertson¹, PJ Nestel², MJ Ball¹
¹School of Human Life Sciences, University of Tasmania, TAS 7250
²Baker Heart Research Institute, Melbourne VIC 8008
27.9 ± 10.430.5 ± 7.0 *gDietary fibre
Table 1. Daily macronutrient intake on intervention 
diets.
Diet  (mean ± SD) n=43UnitMacronutrient
%E percent energy; %TF percent total fat; 
* significant difference (Repeated measures ANOVA, p<0.05)
40.6 ± 7.137.3 ± 8.5 *%TF- Monounsaturated
15.8 ± 4.717.1 ± 5.2%TF- Polyunsaturated 
39.2 ± 6.738.0 ± 7.8%TF- Saturated 
33.1 ± 6.432.0 ± 6.6%ETotal fat
44.1 ± 6.145.8 ± 6.4 *%ECarbohydrate
19.0 ± 2.918.1 ± 2.7%EProtein
8.5 ± 3.08.3 ± 2.3MJTotal energy
Wheat Chickpea 
TC serum total cholesterol; LDL-C serum low density lipoprotein-
cholesterol
HDL-C serum high density lipoprotein-cholesterol 
* significant difference (Repeated measures ANOVA, p<0.05)
1.48 ± 0.661.43 ± 0.83mmol/LTriglycerides
1.37 ± 0.321.34 ± 0.32mmol/LHDL-C
3.87 ± 0.843.69 ± 0.81*mmol/LLDL-C
5.91 ± 0.955.68 ± 0.97*mmol/LTC
WheatChickpeaUnitAnalyte
Diet (mean ± SD), n=47
Table 2. Lipid profiles of participants after each 
diet.
This study was funded by the Grain Research Development Corporation, Australia. Research space was kindly provided by the Clifford Craig Medical Research Trust, Launceston, 
Tasmania.
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Effects of a controlled diet supplemented with chickpeas versus wheat on 
serum lipids, glycaemic control, satiety and bowel function 
JK Pittaway, KDK Ahuja, IK Robertson, MJ Ball 
School of Human Life Sciences University of Tasmania, Launceston, TAS 7250 
 
Background - Chickpeas are common in many ethnic diets and are rich in polyunsaturated fatty 
acids (PUFA), dietary fibre and resistant starch. However, little information is available on the 
health effects of regular chickpea consumption. 
Objective - To compare the effects of a diet supplemented with chickpeas to a wheat-
supplemented diet of similar fibre content on serum lipids and glycaemic control, and to compare 
these diets plus a wheat based diet of low fibre content on satiety and bowel function.  
Design - Twenty-seven free-living adults followed two randomized, crossover dietary 
interventions each of five weeks duration. The chickpea diet included canned chickpeas 
(140g/day), bread and biscuits containing 30% chickpea flour. The diets were isoenergetic to the 
participants’ usual diet, matched for macronutrient content and controlled for dietary fibre. 
Following on from the second randomised intervention, a sub-group of 18 participants underwent 
a third lower-fibre wheat diet. Measures at the end of the diets were compared by repeated 
measures ANOVA using GLM.  
Outcomes - Serum TC was 0.25 mmol/L (p< 0.01) and LDL-C was 0.20 mmol/L lower (p=0.02) 
following the chickpea diet compared to the wheat diet. An unintended significant increase in 
PUFA and corresponding decrease in MUFA consumption occurred during the chickpea diet and 
statistical adjustment for this reduced the effect on serum lipids by about 50%. There was no 
significant difference in glucose or insulin concentrations. Perceived general bowel health 
improved significantly during the chickpea diet although there was considerable individual 
variation. Greater satiety was reported by some participants and was significantly greater than 
on the low fibre diet. 
Conclusions - The small but significantly lower serum TC and LDL-C during the chickpea diet 
could provide a valuable health benefit. 
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Chickpeas influence P:S ratio and fibre content of ad libitum dietary intake 
leading to improved serum lipid profile, glycaemic control and satiation 
JK Pittaway, IK Robertson, MJ Ball 
School of Human Life Sciences, University of Tasmania, Launceston Tas 7250 
 
Background - There has been a gradual development of interest in the contribution of pulses to 
a healthy lifestyle, as awareness of ethnic diets and lifestyles has grown. Controlled dietary 
intervention studies with chickpeas have shown a small but significant reduction in serum low 
density lipoprotein (LDL-C) and total cholesterol (TC) concentrations in women and men. What 
would be the effect of chickpeas on nutrient intake, metabolic and physiological changes in a 
more realistic ad libitum setting? 
Objective - To estimate the effect of including a realistic quantity of chickpeas in an otherwise 
ad libitum diet of free-living adults. 
Design - Ordered crossover design of 20 weeks duration. Forty-five adult women and men, as a 
group slightly hypercholesterolaemic but normoglycaemic, included 104g of chickpeas per day in 
their habitual diet for 12 weeks. 
Comparison of macronutrient and dietary fibre consumption, body weight, body mass index, 
fasting plasma glucose, serum lipids, lipoproteins, insulin, leptin and ghrelin concentrations, after 
habitual diet supplemented with chickpeas and after four weeks of post chickpea ad libitum diet. 
Semi-quantitative assessment of bowel function and satiation using anchored visual analogue 
scales. All data was analysed with repeated measures ANOVA using GLM with robust standard 
error estimation and ordinal logistic regression for ordinal data. 
Outcomes - Chickpea-related increases in mean dietary fibre and PUFA intake were associated 
with significant decreases in serum TC and LDL-C, fasting insulin and HOMA-IR (p<0.05 for all) 
when compared to the usual dietary phase. Small but significant reductions in body weight 
(p=0.001) with increased perceived satiation and improved bowel function were noted during the 
chickpea phase compared to the usual dietary phase. 
Conclusion - Adding chickpeas to the diet is an option for individuals wanting to modify their 
diet-associated CVD risk factors. 
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